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Given the rapidly aging population, the global pace of research has accelerated 
with regards to potentially modifiable risk factors for dementia, including hearing 
loss. While there is a growing body of knowledge on the association between 
hearing loss and dementia, significant gaps remain. 
Objectives 
Our objective is to further characterize and provide context to our current 
knowledge of the association between hearing loss and dementia. We first 
complete an in-depth review of available evidence geared towards audiologists 
and auditory scientists, and provide clinical implications and ideas for future 
directions (Aim 1, Chapter 2). We then evaluate how hearing loss fits within the 
broader framework of risk for dementia and late-life mental health conditions, 
both as it may influence other risk factors (i.e., depression) (Aim 2, Chapter 3) as 
well as how the combination of both risk factors may further influence cognitive 
outcomes, including cognitive decline and dementia (Aim 3, Chapter 4).  
Methods 
For Aims 2 and 3, we leveraged data from the Health, Aging, and Body 
Composition Study, a longitudinal cohort of high-functioning community-dwelling 
older adults aged 70-79 years at baseline (1997-1998) from Memphis, 
Tennessee or Pittsburgh, Pennsylvania. In Aim 2, we compared varied definitions 
of depressive symptomatology to assess prevalence, incidence, and trajectory of 




regression, discrete-time proportional hazard models, and generalized mixture 
models followed by multinomial logistic regression, respectively. In Aim 3, we 
similarly use multiple means of operationalizing depressive symptomatology to 
investigate if the additional presence of depressive symptoms among those with 
hearing loss alters rates of cognitive decline or risk for incident dementia using 
linear mixed effects models and Cox proportional hazard models. 
Results 
Results of our primary analysis indicate that 1) hearing loss is associated with 
increased risk for depressive symptomatology in older adults; 2) a moderate or 
greater hearing loss alone leads to faster rates of cognitive decline and greater 
risk for incident dementia; and 3) individuals with hearing loss who additionally 
developed depressive symptoms overall presented the greatest estimated risk for 
both rates of cognitive decline and risk of incident dementia. 
Conclusions 
Hearing loss may increase risk for late-life mental health conditions including 
depressive symptomatology, cognitive decline, and dementia. Consideration of 
hearing loss and its management within the context of other dementia risk 
factors, may aid in intervention and prevention strategies for late-life cognition. 
Continued targeted investigation of the hearing-depression-dementia association 
has potential for far-reaching public health benefit for older adults, their loved 
ones, and our aging society.  
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Given the rapidly aging population, the global pace of research has 
accelerated with respect to potentially modifiable risk factors for dementia, 
including hearing loss. While there is a growing body of knowledge on the 
association between hearing loss and dementia, significant gaps in our 
understanding remain1. The work presented here first aims to highlight these 
gaps within the context of what we currently know regarding hearing loss and 
dementia. We posit ways in which we might conduct targeted research to 
address such gaps. A comprehensive review of dementia, current evidence on 
the association between hearing loss and dementia, and proposed mechanism(s) 
behind the association is thoroughly discussed in Chapter 2. We consider how 
hearing loss may potentially fit into a broader framework of late-life mental health 
and risk factors for dementia. We quantify how hearing loss might increase risk 
for depressive symptoms- itself an independent risk factor for dementia2, and 
which presents opportunity for intervention along the pathway to dementia. We 
lastly investigate how the additional presence of depressive symptoms among 
those with hearing loss might alter dementia risk for hearing impaired older 
adults.  
Our overall objective is to further characterize and provide context to our 
current knowledge of the association between hearing loss and dementia. With 
the high prevalence of hearing loss, understanding how this impairment may 
influence other risk factors for dementia, or how the combined effect of additional 




present additional avenues for intervention strategies with widespread clinical 
and public health import.  
 
1.2 Epidemiology of Dementia  
In a 2020 report1, the Lancet Commission on Dementia Prevention, 
Intervention and Care estimated up to 40% of dementia cases might be 
preventable through intervention on modifiable dementia risk factors. These risk 
factors include lower educational attainment, hypertension, smoking, obesity, 
depression, physical inactivity, diabetes, infrequent social contact, excessive 
alcohol consumption, head injury, air pollution, and notably, hearing impairment. 
Among these modifiable risk factors, it was estimated that intervention on hearing 
impairment could prevent or delay up to 8% of dementia cases. The 
disproportionate weight attributed to hearing loss is due, in part, to the high 
prevalence of hearing loss in the older adult population. It is estimated that two-
thirds of adults over the age of 70 years have bilateral hearing loss, with 
significant growth in the population prevalence of hearing loss expected in the 
coming decades as the population ages3-5. In addition to its high prevalence, 
hearing loss has a strong relationship with dementia. Hearing impairment is 
associated with an estimated 94% increase in risk of dementia over time6 
compared to non-hearing impaired. We provide a more detailed discussion of 
dementia from a population-based perspective, review the current evidence for 
the hearing-dementia association, and discuss the potential mechanism(s) 




auditory science and hearing health may fit into the broader picture of dementia 
prevention, we must first understand the role and presentation of dementia within 
the U.S. population.  
 1.2.1 The prevalence and cost of dementia care 
In the U.S., an estimated 5.8 million individuals were living with 
Alzheimer’s disease in 2020, with expected increase to nearly 14 million by 
20505. The growing prevalence of dementia translates to increased financial, 
social, and emotional burdens on both communities and families. The 
astronomical financial and emotional costs of dementia are among the many 
drivers behind the research for prevention or intervention at all stages of 
cognitive aging. Identification of additional avenues or means to enhance current 
strategies, particularly if intervention may influence multiple risk factors for 
dementia, has the potential to make substantial contributions to broader 
dementia prevention efforts. 
1.2.2 Identifying Dementia 
 Cognitive decline may be thought of as a trajectory along a continuum 
spanning normal cognition, expected cognitive changes observed with aging, 
mild cognitive impairment (MCI), and dementia7. Cognitive decline then 
represents a change in cognitive functioning from an individual’s prior ability8. 
While a general decrease in cognitive performance is anticipated with increasing 
age for many cognitive processes, particularly processing speed and memory9, 
departures from prior ability greater than that expected for an individual’s age 




Importantly, defined cut-points between age-expected cognitive ability, MCI, and 
dementia currently do not exist.  Therefore, diagnoses are made based on 
clinical expertise and judgement and may be supported by pathophysiology (e.g., 
labs, imaging) if available7.  
Clinical diagnosis of dementia is made by a careful history and physical 
exam, cognitive testing, laboratory, and imaging studies10. Neurocognitive 
evaluations are instrumental components in a provider’s clinical examination of a 
patient’s cognitive status. The assessments evaluate global cognitive 
performance or cognitive ability within five recognized cognitive domains: 
memory, attention, executive function, language, and visuospatial. This variety of 
available cognitive tests are completed across visual and auditory modalities.  
1.2.3 Dementia Prevention 
What remains clear is that the expected growth in dementia cases 
worldwide requires action on dementia prevention and intervention, as currently 
there is no FDA approved disease modifying treatment for Alzheimer’s disease 
and related dementias. Current treatment considerations for most forms of 
dementia have the goal of delaying or minimizing the impact of clinical symptoms 
for a period of time1. In the absence of a cure, the primary objective of 
epidemiologic research is to identify dementia risk factors associated with 
pathologic progression or dementia diagnosis, or identify factors associated with 
the progression of dementia symptoms. Subsequent goals of this research are to 
then identify opportunities to prevent or postpone dementia along the continuum. 




implementation and delaying of dementia onset, which could have great 
implications at the population level. An intervention that could delay the onset of 
dementia by 5 years could lead to a 57% reduction in the number of patients with 
dementia13 and 40% lower cost by 205011.  
Research over the last few decades has sought to determine what role 
hearing loss may play in these global efforts for dementia prevention. Discussion 
of this research is completed in Chapter 2. With this thesis we aim to contribute 
to these efforts. 
 
1.3 Hearing Loss in Older Adults 
1.3.1 Epidemiology of Hearing Loss 
The World Health Organization’s 2021 World Report on Hearing12 
projected 1 in 4 people globally will have hearing difficulty by 2050 due to a 
global demographic shift to older populations. As previously stated, hearing loss 
has a high prevalence in older adults, doubling every 10 years after age 5013 — 
its prevalence is 15% of those age 50-59 yet rises to 80% for those 85 and older 
in the United States. In addition to greater risk for diagnosis of hearing loss with 
increasing age, severity of hearing loss increases with each decade of life, with 
those over 80 years of age presenting a higher likelihood of moderate or greater 
hearing loss than mild hearing loss for the first time4. However, analysis in a 
nationally representative sample of older adults suggests the prevalence of 




estimated decrease of about 2% in adults compared to the prior decade. 
Improvements in health care or access to care and prevention of known risk 
factors for hearing loss likely contribute to this observed decrease.  
Prevalence of hearing loss varies by non-modifiable factors such as 
certain identified syndromes and genetic factors12. Additional non-modifiable 
factors include race and gender with a lower prevalence of hearing loss noted 
among women compared to men and Black adults compared to Hispanic or non-
Hispanic White adults4, 13. Characterizing differences in downstream effects of 
hearing loss by race and gender may offer opportunities for creative prevention 
strategies given differing social factors across subgroups which may influence 
neuropsychological outcomes15-16. 
 Additional potential causative risk factors for hearing loss across the life 
course have also been identified12. While many risk factors for hearing loss stem 
from prenatal or perinatal causes/determinants (i.e., intrauterine infections, 
delivery complications), other risk factors for hearing loss in adolescence and 
adulthood have also been identified12. These include: otitis media (i.e., ear 
infections), viral infections or pathogens (i.e., measles, mumps, meningitis, HIV, 
Lassa virus, Ebola), chronic disease (i.e., hypertension, cardiovascular disease, 
diabetes), smoking, use of ototoxic medications, head trauma, excessive noise 
exposure from occupational, recreational, or environmental noise, ear-related 
conditions such as Meniere’s disease, autoimmune disease, or vestibular 
schwannomas, and nutritional deficiencies from nutrients like Vitamin A, zinc, 




age due to age-related sensorineural hearing loss. This is a multifactorial 
condition thought influenced by genetics, environmental factors, lifestyle, and 
illnesses. While it is not yet determined if all of these factors are causal, each is 
correlated with increased risk of hearing loss.  
1.3.2 Measuring Hearing Ability 
The act of hearing involves two inter-related processes and components 
of the auditory system – the peripheral hearing system and the central hearing 
system17- with unique measurement tools for each component. Both parts of the 
auditory system must work in tandem for an individual to appropriately detect and 
understand a sound. This process is essential for auditory interaction with the 
environment and for quality communication. Yet most commonly, it is the 
peripheral hearing system that is considered in discussion of hearing loss. The 
few epidemiologic studies that include a formalized measure of hearing primarily 
consider peripheral hearing ability alone. Moreover, many epidemiologic studies 
rely on self-reported measures of hearing. Self-report hearing considers 
perceived functional ability of hearing, incorporating aspects of the peripheral and 
central hearing system as well as the social environment and listening demands. 
1.3.2.a Peripheral hearing system 
The peripheral hearing system includes the outer ear (pinna), ear drum 
(tympanic membrane), middle ear bones (malleus, incus, and stapes) and 
cochlea17 (Figure 1.1a). These components work together to channel the 
incoming auditory sound waves from the outer ear down the ear canal, and 




signal in the cochlea17. While a discussion of the complete anatomy and 
physiology of the peripheral hearing system is beyond the focus of this thesis, an 
individual’s ability to detect the presence of auditory stimuli initiates within and is 
dependent upon the peripheral system.  
The most common clinical tool for measurement of peripheral hearing 
acuity in adults is audiometry, with results graphically recorded on an 
audiogram18. The gold standard for testing is performed in a sound-proof booth 
using headphones. An auditory stimulus (i.e., pure tone) is presented at a 
particular frequency (Hz) at a given volume commonly within the range of 500-
8000 Hz. The volume of each pure tone is lowered until the lowest volume level, 
the threshold in decibels hearing level (dB HL), at which the individual indicates 
detection of the tone. Results are often summarized as a four-frequency pure 
tone average (PTA), or the average of responses at 500, 1000, 2000, and 4000 
Hz18. Consideration can be made if this average should be calculated from 
results from the better or poorer hearing ear depending on study question or 
objective. 
1.3.2.b Central hearing system 
Following passage through the peripheral auditory system, the electrical 
signal created by the cochlea is sent to the auditory nerve where it is then 
decoded by the brain17 (Figure 1.1b). Central hearing ability is therefore 
dependent upon the integrity of the auditory signal passed from the peripheral 
hearing system as well as additional cognitive processing19. While peripheral 




ability then is the ability for the brain to understand and make sense of this 
sound, requiring significantly higher-level processing.  
Measurement of central hearing is commonly completed through the 
presentation of speech within the presence of increasing volume of background 
noise (i.e., speech-in-noise testing) or specialized tests of central auditory 
processing ability19, but is far less frequently completed in both clinical visits as 
well as in large scale epidemiologic studies. This interdependence between 
central hearing ability and cognitive processing blurs the distinction between the 
two processing abilities. In addition, heterogeneity in prior study of this work has 
created significant barriers to pooled evidence and causal inference regarding 
the role of central hearing ability in late-life mental health. While beyond the 
scope of this dissertation, a functional understanding of both aspects of the 
hearing system is important when considering dementia prevention strategies. 
1.3.3 Modifiability of hearing loss 
 Historically, hearing loss has been considered a benign component of the 
aging process resulting primarily in impaired communication. However, research 
over the last few decades has highlighted hearing loss as a precipitating factor 
for additional functional and neuropsychiatric disorders in older adults and has 
spurred changes in thought within the medical and public health community20-22. 
Importantly, hearing loss is generally considered modifiable through 
amplification. Therefore, the scientific and clinical community has begun to 
recognize the potential protective benefit of hearing loss management, 




Therapeutic opportunity exists, as hearing aids are vastly underutilized: on 
average only ~30% of eligible adults obtain hearing aids13. While significant 
barriers and disparities in hearing health care and accessibility of care and 
services remain, the potential room for intervention growth and public health 
benefit is substantial. Management of hearing loss through amplification options 
may not only decrease risk for neuropsychiatric conditions2, but may also 
improve treatment adherence, patient satisfaction, and improve overall health-
related quality of life for older adults23. Understanding subgroups who may 
receive particular benefit from increased amplification use may therefore save 
health care costs, reduce burden, and improve outcomes. 
 
1.4 Hearing loss in the presence of other geriatric conditions 
What has received considerably less study is how the presence of hearing 
loss, in combination with other complex geriatric conditions, which themselves 
may serve as risk factors for dementia may modify dementia risk and other 
psychosocial outcomes for older adults. Around 67% of older adults of Medicare 
age have multimorbidity24. Given the high prevalence of hearing loss, hearing 
impairment is likely present in older adults along with other health conditions. 
Therefore, the study of differences in dementia risk by subgroups of older adults 
with concurrent modifiable risk factors for cognitive decline could have 




In the Lancet report1, late-life depression was thought to contribute to 
nearly 4% of potentially preventable dementia cases. Similar to hearing loss, 
late-life depression presents a 90% greater risk of dementia; however, the lower 
prevalence of diagnosed depression at 13.2% contributes to the lesser-weighted 
fraction of potentially preventable cases1. Much remains to be clarified in how 
diagnosed depression or the presence of clinically significant depressive 
symptoms is associated with dementia, as depression is currently recognized as 
both a risk factor and a prodromal sign of dementia1. Importantly, while evidence 
is mixed, prior work suggests hearing loss may increase risk of depression or 
depressive symptoms in older adults25-28. However, prior research has not 
accounted for the heterogeneous course of depressive symptomatology over 
time. Older adults with hearing loss may avoid social situations or have difficulty 
engaging with surroundings and loved ones due to difficulty communicating in 
challenging listening situations. Further, changes in brain structure due to 
hearing loss may lead to elevated vulnerability for depressive symptomatology or 
result in behaviors that can increase social isolation and risk for depression2. 
Recent hypotheses suggest the psychosocial effect of hearing loss may differ not 
only by environment and listening needs, but also by race and gender. While it is 
unclear if depressive symptoms may mediate or modify the hearing and 
dementia association, it is valuable from clinical and public health lenses to 
quantify how the presence of these risk factors influence cognitive outcomes. 




symptoms and dementia may present novel opportunity for public health 
prevention and intervention options for dementia in older adults.  
1.5 Study Description  
The work presented in this thesis addresses gaps in our understanding of 
the clinical relevance and public health burden of hearing loss on late-life mental 
health. Quantifying the role that hearing loss may have within the milieu of late-
life mental health may present underutilized opportunities for intervention and 
prevention efforts, as depicted in our conceptual framework (Figure 1.2).  
1.5.1 Health, Aging, and Body Composition Study 
The analyses conducted and presented here in Chapters 3 and 4 use data 
from the Health, Aging, and Body Composition Study (Health ABC).  The Health 
ABC study, began in 1997-1998, is a prospective study with up to 16 years of 
follow-up. The study was designed to evaluate risk factors associated with a 
decline in function in healthier older adults, including evaluation of differences in 
the onset of functional limitations, disability, and longevity by sex and race (Black 
vs White). Of particular benefit to our work was a focus when designing the study 
to allow for assessment of multi-morbidity on these outcomes. The study enrolled 
3,075 well-functioning, community-dwelling Black or White older men and women 
aged 70-79 years at baseline from Pittsburgh, Pennsylvania and Memphis, 
Tennessee29. Participants were selected for inclusion in this study if they 
reported no difficulty walking ¼ mile or climbing up 10 steps. Follow-up consisted 




2013. Audiometry was conducted at the study visit during the 5th year of follow-
up. 
1.5.2 Aim 1: Hearing and Cognition in an Aging World 
In Chapter 2, we present a comprehensive review of the state of the 
research on the association between hearing loss and dementia. We (1) provide 
a foundational understanding of dementia epidemiology, presentation, and 
diagnosis in the United States; (2) contextualize research on the association 
between hearing loss and dementia to guide dementia prevention and 
intervention; (3) review mechanistic theories about the hearing-dementia 
association; (4) review priorities for future research; and (5) provide a perspective 
on how we can utilize current and future evidence to improve patient care. We 
conclude by presenting a call for multi-disciplinary collaboration for the 
advancement of our understanding of the hearing-dementia association and 
future intervention strategies. 
1.5.3 Aim 2: Hearing Loss and Risk of Depressive Symptoms in Older 
Adults 
The purpose of this study was to investigate if hearing loss is associated 
with greater prevalence of depressive symptoms, greater incidence of depressive 
symptoms, or is associated with a greater increase in depressive symptoms over 
time. We further investigate racial and gender differences in the association. We 
hypothesized hearing loss is associated with greater risk for the presence and 
new occurrence of depressive symptoms as well as larger changes in severity of 




study included varied measures of depressive symptoms to attempt to capture 
the heterogeneous course of depression in older adults. We used logistic 
regression to investigate the odds of clinically significant depressive symptoms 
by hearing status, and discrete-time proportional hazard models to quantify risk 
of incident clinically significant depressive symptomatology. Lastly, we used 
generalized mixture modeling to create classifications of trajectories for change 
in depressive symptoms over time. We then used multinomial logistic regression 
to describe the relative risk ratio of belonging to a particular depressive symptom 
trajectory by hearing status.  
1.5.4 Aim 3: Examining the Combined Estimated Effects of Hearing 
Impairment and Depressive Symptoms on Risk of Cognitive Decline and 
Incident Dementia 
In our last paper, we aimed to test if (i) rates of cognitive change and (ii) 
risk of incident dementia, differ for participants with both hearing loss and 
depressive symptoms compared to what would be expected given their 
independent effects. We hypothesized the additional presence of depressive 
symptomatology among hearing impaired older adults demonstrates faster rates 
of cognitive decline and greater risk of incident dementia. We created a four-
category exposure for this analysis 1) normal hearing or mild loss (reference 
category), 2) moderate or greater hearing loss only, 3) clinically significant 
depressive symptoms only, and 4) both moderate or greater hearing loss and 
clinically significant depressive symptoms.  We again used multiple measures of 




symptomatology over time. We used linear mixed effects models with subject 
specific slopes and intercepts to evaluate rates of cognitive change over up to 8 
years of follow-up by hearing and depression status. We then aimed to evaluate 
risk for incident dementia by hearing and depression status using Cox 
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FIGURE 3. A) Peripheral hearing system including the pinna, ear 
canal, tympanic membrane, ossicles and cochlea. B) Central hearing 
system incorporating the auditory nerve, parts of the brain stem and 































With the increasing number of older adults around the world, the overall number 
of dementia cases is expected to rise dramatically in the next 40 years. In 2020, 
nearly 6 million individuals in the U.S. were living with Alzheimer’s disease, the 
most common type of dementia, with anticipated growth to nearly 14 million by 
year 2050. This increasing prevalence, coupled with high societal burden, makes 
prevention and intervention of dementia a medical and public health priority. As 
clinicians and researchers, we will continue to see more individuals with hearing 
loss with other comorbidities including dementia. Epidemiologic evidence 
suggests an association between hearing loss and increased risk of dementia, 
presenting opportunity for targeted intervention for hearing loss to play a 
fundamental role in dementia prevention. In this discussion, we summarize 
current research on the association between hearing loss and dementia and 
review potential casual mechanisms behind the association (e.g. sensory-
deprivation hypothesis, information-degradation hypothesis, common cause). We 
emphasize key areas of research which might best inform our investigation of 
this potential casual association. These selected research priorities include 
examination of the causal mechanism, measurement of co-existing hearing loss 
and cognitive impairment, and potential of aural rehabilitation. Addressing these 
research gaps and how results are then translated for clinical use is paramount 






In both the initial 2017 and updated 2020 Lancet Commission reports on 
dementia prevention1-2, hearing loss was identified as the leading potentially 
modifiable risk factor for dementia. A sharp increase in research on the 
association between hearing loss and dementia has developed over the past 
decade, building upon initial research from decades ago. As early as 1968, in an 
experimental condition designed to mimic hearing loss and decreased speech 
intelligibility, participants demonstrated increased difficulty of performance on 
word-recall cognitive tasks compared to normal listening conditions3. Some 
twenty years later, a landmark case-control study4 reported higher odds of 
dementia in those with hearing loss compared to normal hearing.  
Given the rapidly aging population, the global pace of research has 
accelerated with regards to potentially modifiable risk factors of dementia, 
including hearing loss. While there is a growing body of knowledge on the 
association of hearing loss with dementia, significant gaps remain in our 
understanding. In this article, we aim to (1) provide a foundational understanding 
of dementia epidemiology, presentation, and diagnosis in the United States; (2) 
contextualize research on the association between hearing loss and dementia to 
guide dementia prevention and intervention; (3) review mechanistic theories 
about the hearing-dementia association; (4) review priorities for future research; 
and (5) provide a perspective on how we can utilize current and future evidence 




coming decades and posit that targeted collaboration between the auditory 
science and cognitive science communities may present a unique opportunity to 
alter the landscape of cognitive aging and dementia care.  
2.2 Epidemiology and Clinical Diagnosis of Dementia   
In its 2020 updated report, the Lancet Commission estimated up to 40% of 
dementia cases could, in theory, be prevented through intervention on modifiable 
dementia risk factors2. These risk factors include lower educational attainment, 
hypertension, smoking, obesity, depression, physical inactivity, diabetes, 
infrequent social contact, excessive alcohol consumption, head injury, air 
pollution, and notably, hearing impairment. Among these modifiable risk factors, 
it was estimated that intervention on hearing impairment could prevent or delay 
up to 8% of dementia cases. The disproportionate weight attributed to hearing 
loss is due, in part, to the high prevalence of hearing loss in the older adult 
population. It is estimated that two-thirds of adults over the age of 70 years have 
bilateral hearing loss, with significant growth in the population prevalence of 
hearing loss expected in the coming decades as the population ages5-7 (Figure 
2.1). In addition to its high prevalence, hearing loss has a strong relationship with 
dementia. Hearing impairment is associated with an estimated 94% increase in 
risk of dementia over time1 compared to non-hearing impaired. We provide a 
population-based perspective and review of the evidence leading to this high 
level of risk and discussion of the potential mechanism behind this risk in the 




picture of dementia prevention, we must first understand the role and 
presentation of dementia within the U.S. population.  
2.2.1 The Prevalence and Cost of Dementia 
By 2034, the population over the age of 65 years in the U.S. is projected 
to outnumber those under the age of 19 years for the first time in U.S. history8. 
Moreover, by 2060 the number of individuals over the age of 65 will almost 
double from 49 million in 2016 to over 94 million8. In the U.S., an estimated 5.8 
million individuals were living with Alzheimer’s disease in 2020, which is 
expected to increase to nearly 14 million by 20505. The growing prevalence of 
dementia translates to increased financial, social, and emotional burdens on both 
communities and families. The total cost of care for those over 65 years living 
with dementia in the U.S. is estimated at $305 billion in the year 2020 alone5. 
Family and social care accounts for up to 85% of the cost of care for those with 
dementia1. In 2019, 16 million family members in the U.S. provided over 18.6 
billion hours of care to individuals with Alzheimer’s disease, a labor cost valued 
at $244 billion5 – cost that often goes unrecognized. These numbers do little to 
express the social and emotional strain on individuals and families who are 
providing or requiring care. The astronomical financial and emotional costs of 
dementia are among the many drivers behind the research for prevention or 
intervention at all stages of cognitive aging.  
2.2.2 Identifying Dementia 
 Cognitive decline may be thought of as a trajectory along a continuum 




mild cognitive impairment (MCI), and dementia (Figure 2.2). Cognitive decline 
then represents a change in cognitive functioning from an individual’s prior 
ability9. While a general decrease in cognitive performance is anticipated with 
increasing age for many cognitive processes, particularly processing speed and 
memory10, departures from prior ability greater than that expected for an 
individual’s age and education suggests possible transition along the clinical 
spectrum.  
Broadly, mild cognitive impairment refers to a symptomatic predementia 
phase in which the cognitive impairment demonstrated is beyond that expected 
based on age, education history or other individual characteristics11. A formal 
diagnosis of MCI is made via clinical, cognitive, and functional observed 
criteria11. MCI is considered if concern over a change in cognition from previous 
ability is expressed from the individual, informant, or clinician, and if cognitive 
performance is poorer in one or more cognitive domains (e.g., memory, 
executive function, attention, language, and visuospatial skills) compared to that 
expected based on age and educational background. With MCI, while difficulty 
may exist performing complex tasks, the individual can maintain independence 
with everyday functional activities or requires minimal assistance for social or 
occupational functioning9,11. The diagnosis progresses to dementia when the 
symptoms of cognitive impairment begin to interfere with the individual’s 
independence in everyday activities12. Of paramount importance to 
understanding research challenges of dementia is the generally insidious 




disease and related dementias (ADRD) are generally slow and progressive 
disorders without a definitive onset or clear transition points between an 
asymptomatic phase, symptomatic predementia phase, and the transition to 
dementia12.  Importantly, defined cut-points between age-expected cognitive 
ability, MCI, and dementia currently do not exist.  Therefore, diagnoses are made 
based on clinical expertise and judgement and may be supported by 
pathophysiology (e.g., labs, imaging) if available13. Readers may seek additional 
information elsewhere for the distinctions between clinical based dementia 
diagnosis and diagnosis in research studies which follow a different framework 
for diagnosis recommendations11-14. 
Clinical diagnosis of dementia is made by a careful history and physical 
exam, cognitive testing, laboratory, and imaging studies. Neurocognitive 
evaluations are instrumental components in a provider’s clinical examination of a 
patient’s cognitive status. As such, an abundance of neurocognitive tests exist to 
inform clinical judgement. The assessments evaluate global cognitive 
performance or cognitive ability within five recognized cognitive domains: 
memory, attention, executive function, language, and visuospatial. This variety of 
available cognitive tests are completed across visual and auditory modalities, 
including some designed to be administered over the phone.  
In contrast to the criteria for clinical diagnosis described above, 
recommendations for criteria for diagnosis in a research setting allow for the 
additional incorporation of biomarkers. Biomarkers are loosely categorized as 




injury11,13-14. Importantly, the biomarkers within each category are not 
necessarily specific to Alzheimer’s disease (AD) and may be indicative of AD as 
well as other dementia etiology. In research regarding preclinical dementia, 
biomarkers are used to identify participants with AD pathophysiology with 
emphasis placed on the hypothesized ordering to biomarker presentation14. 
However, in MCI or AD related research, usage of biomarkers for diagnosis is 
more conservative due to an expressed need for additional outcomes 
research13. While biomarkers suggesting amyloid pathology are thought to 
precede neuronal injury in research settings, much remains to determine how 
biomarkers may be used to determine dementia etiology and prognostication, or 
their utility in short vs long term dementia trajectories before widespread use in 
clinical diagnosis11. The variety of diagnostic criteria across phase of dementia 
progression within clinical versus research setting presents challenges to 
summarizations and inference of this research. 
Alzheimer’s disease is recognized as the most common type of dementia5, 
but increasing evidence recognizes that many older adults demonstrating 
cognitive impairment have mixed pathology15. Other types of dementia such as 
vascular dementia, dementia with Lewy bodies, and frontotemporal dementia 
should also be recognized and represent different etiology. While biomarker 
testing for AD (e.g., amyloid-PET, CSF amyloid-beta and tau) is not required, if 
available it increases the certainty that the dementia is due to the AD 
pathophysiological process versus other dementias and could aid in disease and 




there are on-going studies to examine its utility16. Some biomarkers that are 
thought to be characteristic of AD may also be seen in other dementias. The last 
few decades have informed our understanding of progression of dementia 
pathophysiology and the connection to disease stage and the pathophysiologic 
process. However, as noted, a biomarker-based diagnosis is currently only 
supported for research-based diagnosis13 and remains to be clarified for clinical 
use12.   
As discussed, current evidence suggests a pre-clinical asymptomatic 
phase may be years if not decades for some individuals13,17. A long pre-clinical 
phase of disease presents challenges for epidemiologic studies and interventions 
or trials for dementia, yet provides opportunity for early detection and potential 
prevention of clinical symptom progression. Further clouding the diagnostic 
picture, not all individuals who demonstrate the neuropathological hallmarks of 
AD with amyloid beta accumulation and tau protein will develop clinical 
symptoms (i.e., cognitive decline or functional impairment) during their lifetime. 
Alternatively, some individuals may demonstrate significant cognitive impairment 
early with fewer pathologic changes14,18. The imperfect relationship between 
pathological changes and the presentation of symptoms opens questions of what 
contributes to this varied presentation of disease, and makes clinical prediction 
for the progression of disease challenging. 
2.3.3 Dementia Prevention  
What remains clear is that the expected growth in dementia cases 




there is no FDA approved disease modifying treatment for ADRD. Current 
treatment considerations for most forms of dementia have the goal of delaying or 
minimizing the impact of clinical symptoms for a period of time2. In the absence 
of a cure, the primary objective of epidemiologic research is to identify dementia 
risk factors associated with pathologic progression or dementia diagnosis, or 
identify factors associated with the progression of dementia symptoms. 
Subsequent goals of this research are to then identify opportunities to prevent or 
postpone dementia along the continuum. With identification of such risk factors, 
we may then emphasize research on the implementation and delaying of 
dementia onset, which could have great implications at the population level. An 
intervention which could delay the onset of dementia by 5 years could lead to a 
57% reduction in the number of patients with dementia14 and 40% lower cost by 
205019. With foundational evidence of the association between hearing 
impairment and dementia from epidemiologic research, the expertise and 
potential collaboration between auditory scientists and disciplines involved with 
cognitive aging may enrich our evidence base and contribute towards prevention 
and intervention efforts. 
2.3 The Link between Hearing and Dementia– What We Know Now 
 In this review, we will primarily highlight evidence of the association and 
potential causal effect within studies with completed objective measures of 
auditory function. Self-reported hearing is important, but also incorporates an 
individual’s perception of their hearing and communication ability (i.e. 




Significant heterogeneity in study methodology and study design exists, 
making comparisons and data synthesis across studies challenging. Prior work 
has varied in audiometric parameters to define hearing loss, auditory frequencies 
used, sample size, study population, consideration of potential confounders, and 
how dementia was measured and operationalized, to name a few. Differing ways 
of measuring cognitive impairment or dementia are particularly challenging as 
different criteria may be used across studies.  Dementia ascertainment in studies 
through medical chart history compared to clinical, research-based settings, or 
in-person dementia diagnosis may introduce variability in dementia diagnosis 
across studies. Therefore cognitive function may be assessed in a variety of 
formats depending on the clinical or research environment. A wide variety of 
additional neurocognitive tests and test batteries across cognitive domains 
exist20, in addition to global cognitive screeners (i.e., Mini-Mental State Exam 
([MMSE]21) or the Montreal Cognitive Assessment ([MoCA]22)), to aid in 
evaluation of cognitive function. These test batteries are often comprehensive, 
requiring additional time considerations as well as implementation by trained 
personnel experienced in the delivery of neurocognitive assessments in both 
clinical and research settings.  
2.3.1 Peripheral Hearing Loss 
A handful of previous reviews have provided summaries of current 
evidence on the hearing-dementia association23-27. In perhaps the most rigorous 
review to date, The Lancet Commission1 reported a pooled relative risk from 




dementia among hearing impaired individuals 55 years of age and older 
compared to those with normal hearing. The Commission found only these three 
studies on the association between peripheral hearing impairment and incident 
dementia met the specified inclusion criteria of: audiometrically (objective) 
measured hearing, longitudinal evaluation (at least 5 years), and covariate 
adjustment. Each of these criteria are fundamental components toward 
investigation of causality. Objectively measured hearing is important when 
attempting to isolate the independent effect of hearing loss due to cochlear 
damage on dementia.  Cross-sectional evaluations, where hearing and cognition 
are measured at the same time point, present challenges for causal inference of 
cognitive impairment. With cross-sectional studies, we are not able to assess 
which comes first – hearing loss or dementia. Additionally, cognition is 
particularly susceptible to confounding by psychosocial factors (i.e., episodic 
depression, anxiety, stress, exhaustion, comorbid conditions, or medications) 
when measured at one time point but is less susceptible with longitudinal 
measures.  Therefore, comparing group differences in cognitive test scores 
cross-sectionally may not accurately depict changes in underlying cognitive 
function but may instead include the effect of these other psychosocial factors. 
Additionally, many prior studies failed to account for known additional factors 
(i.e., confounders) which could contribute toward, and therefore cloud, the 
estimated association found between hearing and cognition.  
Other reviews have also reported associations between hearing and 




1.36) or 1.28 (95% CI: 1.02, 1.59) greater odds of cognitive impairment or 
dementia, respectively, for those with age-related hearing loss. In addition, 
hearing loss has been specifically associated with declines in global cognitive 
function, executive function, processing speed, and memory7,24. However, what 
constitutes hearing ability or impairment often differs across studies. Some 
studies have considered hearing continuously per decibels in hearing level (dB 
HL), while others have categorized hearing ability (i.e., mild or greater loss, 
moderate or greater loss, or clinically recognized categories, (WHO Grades of 
hearing)). This heterogeneity of definitions presents challenges for pooling or 
summarizing results across studies. The degree of hearing difficulty varies by 
categorization used and represents different levels of impairment and functional 
ability such as in categorization of those with any measured hearing impairment 
(i.e., Pure Tone Average [PTA] ≥25 dB HL) vs. those with a moderate or greater 
hearing impairment (PTA > 40 dB HL)30.  
Many studies summarize peripheral hearing acuity as a four-frequency 
pure tone average (PTA, 500-4000 Hz). While this is informative and sufficient for 
many hypothesis considering functional performance of hearing acuity, when 
reviewing the potential biological or physiological causal association between 
hearing and dementia, it may also be worth considering specific frequency 
ranges depending on the research hypothesis. Additional heterogeneity in study 
definitions of hearing impairment includes “better” vs. “worse ear PTA.”  Studies 
examining the association of hearing loss and its possible consequences (e.g., 




many of the proposed mechanistic pathways underlying these relationships have 
to do with an individual’s overall hearing ability. In comparison, for studies 
examining biological mechanism and etiology of hearing loss (i.e., hearing loss is 
the outcome of interest), it may be more informative to consider worse ear PTA. 
2.3.2 Central Auditory Function 
While an association between age-related peripheral hearing loss and 
dementia is well established2, the relationship between cognitive 
decline/dementia and central auditory function remains much more abstract. 
Termed cognitive hearing science by some31-32, the interdependence between 
central auditory function and cognitive processing blurs the distinction between 
the two processing abilities. Not only does the integrity of an auditory stimulus 
rely on an accurately encoded signal by a functioning peripheral system, but the 
stimulus must further be decoded by the central auditory system. This decoding 
requires the involvement of higher-level cognitive processes. Distinguishing the 
boundaries between central auditory dysfunction and cognitive impairment has 
been a subject of research for decades33-34. However, as with peripheral hearing 
loss, studies have used a diverse grouping of definitions, tests, cognitive 
domains, and sample populations (e.g., both young and old or hearing impaired 
and non-impaired populations). This heterogeneous operationalization of both 
processing abilities creates significant barriers to pooled evidence and causal 
inference on the hearing-dementia association.  
Dryden et al. systematically reviewed evidence in 2017. While the quality 




adult unaided listeners with normal to moderate hearing loss, a correlation 
between cognitive performance and speech perception was overall weak 
depending on the speech-in-noise test used and cognitive domain of interest, 
with the greatest correlation seen with processing speed. The degree un-aided 
hearing loss plays in moderating the relationship between central auditory 
functioning (e.g., decoding of speech stimuli or speech perception ability in noise) 
and cognitive performance remains to be determined. However, results continue 
to highlight the interdependence of cortical resources utilized during both central 
auditory processing and cognitive processes35-37.   
The interdependence between central auditory function and cognitive 
processing presents challenges to inference but also unique opportunities in 
identifying targets for prevention. Prior work has hypothesized that central 
auditory dysfunction (CAD) may be a prodromal symptom and therefore an early 
marker of cognitive decline in older adults38. AD pathology is known to reach the 
primary auditory cortex. Work conducted nearly 30 years ago demonstrated AD 
pathology of plaques and neurofibrillary tangles within the medial geniculate body 
and central nucleus of the inferior colliculus as well as the primary auditory and 
auditory association cortices of patients diagnosed with AD, but not in non-AD 
elderly patients39. Braak staging40 indicates that auditory association cortices are 
one of the last brain regions affected by AD pathology, supporting central 
auditory dysfunction as a marker of AD, but with unclear indication of CAD as an 
early marker.  In a volunteer sample from a dementia surveillance cohort41, the 




severe central auditory dysfunction, as measured using the Dichotic Sentence 
Identification test, compared to those demonstrating normal central auditory 
function. Further work suggested that the Dichotic Sentence Identification test in 
free report mode may be the most sensitive test for the presence of memory 
impairment among those demonstrating mild memory impairment without 
dementia42. Investigation of the association between central auditory processing 
and biomarkers for AD neurodegeneration including CSF tau, cortical thickness 
and volumetric measures of AD-related brain regions was consistent across 
measures of central auditory processing43. Whether CAD has utility for predicting 
dementia in addition to predictions possible with current ADRD biomarkers has 
yet to be determined. 
The nature of the association between central auditory function, as 
measured via speech-in-noise ability, and cognition may differ by aided vs. 
unaided hearing. Additional work has demonstrated that for aided listening with 
background noise, higher level cognitive processing capacity was the most 
important factor in the differences observed in speech understanding 
performance. In contrast, for unaided listening, peripheral hearing was the 
predominant factor driving performance. For select individuals, high frequency 
hearing played a predominant role regardless of aided status or degree of loss35.  
Some researchers have described an idea of central presbycusis meant to 
represent “age-related auditory processing disorder underlying poor speech 
understanding in noise, competing speech, or distorted speech”44. The existing 




speech and non-speech stimuli. A review of past research45 concluded 
insufficient evidence existed to claim central presbycusis as an independent 
construct, but proposed that it may instead represent a disease manifestation 
from multiple conditions involving age-related or disease-related changes in both 
the auditory system and the brain.  
2.3.3 Management of hearing loss for dementia prevention 
As mentioned, the treatment of hearing loss makes it a worthy target of 
interest among dementia risk factors due to the readily available management 
strategies for hearing loss (e.g. hearing aids). The data on the use of hearing 
aids to decrease risk of cognitive decline in observational or cross-sectional 
studies are mixed46-49. In observational studies, we are often not able to control 
factors which influence if someone becomes a hearing aid user (e.g., higher 
education, higher socioeconomic status, greater access to healthcare), many of 
which are also factors which are protective against dementia. Therefore, it is 
challenging to disentangle the potential effects of hearing aids on cognition 
versus the effect of these other factors, possibly influencing the effect seen and 
therefore introducing bias into our study.  However, the question of whether 
hearing aid use or other treatments for hearing impairment may alter the 
subsequent risk of dementia has begun to receive attention in well-designed pilot 
studies and clinical trials. These clinical trials aid in minimizing this potential bias 
through study design tools such as randomization and masking50. The Aging and 
Cognitive Health Evaluation in Elders (ACHIEVE) pilot study conducted in 40 




outcomes and a suggestion of efficacy in improving or stabilizing memory scores 
(although not powered to detect a difference) for those randomized to the use of 
a hearing aid compared to a successful aging education control51. A full-scale 
(N=977) randomized clinical trial is currently being conducted52. A pilot study of 
hearing aid use by older adults with depression, another possible downstream 
risk of hearing impairment which may mediate or moderate the hearing-dementia 
association, observed small to moderate improvement in depressive symptoms, 
memory, and general cognitive functioning53. Further, consideration of the age 
and rapidity of hearing loss onset and its proximity to hearing aid uptake, and the 
influence of other rehabilitation strategies on dementia risk is vastly 
understudied. 
Several studies have begun to investigate cognitive function among 
cochlear implant recipients following surgery. Work in a pilot sample among 23 
cochlear implant candidates and 16 implant recipients demonstrated better 
performance on measures of reaction time, cognitive flexibility, working memory 
and strategy use compared to implant candidates54. Prospective evaluation of 
cognitive performance among individuals pre and post cochlear implant surgery 
has suggested improved cognitive performance on global cognition or executive 
function post implantation55-56. However, many studies have focused on pre/post 
performance on speech perception, perceived function, and quality of life for 
older adults rather than neurocognitive outcomes specifically. While these 
outcomes are absolutely important, investigation of the impact on cognitive 




assessments in multivariate models with appropriately considered control groups 
are limited57-58. With expanding cochlear implant candidacy and our aging 
population, well designed longitudinal studies could vastly improve our 
understanding and counseling considerations for older adult cochlear implant 
candidates.   
2.4 Mechanistic Theories  
As described above, the association between central auditory function and 
dementia is complex and its interdependence with dementia presents challenges 
for causal inference. Therefore, current mechanistic theories predominantly 
consider peripheral hearing impairment as a potential cause of dementia and 
central auditory function as a marker of cognitive decline. While there are gaps in 
the understanding of mechanism(s) behind the relationship between age-related 
hearing loss and dementia, elucidating these mechanisms is vital for the design, 
implementation, and evaluation of preventive strategies, interventions or 
recommendations for patient care or health policy. Hypotheses on the causal 
mechanism of the association have eloquently been described in prior works59-61. 
While limited evidence supports the notion that dementia leads to hearing 
loss33,62 the direction of the association between age-related hearing loss and 
dementia remains to be clarified. A greater body of evidence supports how age-
related hearing loss may contribute to cognitive decline directly (“sensory-
deprivation” hypothesis) or indirectly (“information-degradation” hypothesis), or 
how both may be the result of an external variable all together (“common-cause” 




theories as depicted in our modified mechanistic framework (Figure 2.3).  
Readers may seek additional evidence for each proposed hypothesis in Wayne & 
Johnsrude (2015) or Lin et al. (2014b).  
2.4.1 Sensory Deprivation Hypothesis 
Evidence suggests that prolonged sensory deprivation due to age-related 
hearing loss has a lasting adverse effect on brain structure and function. Age-
related hearing loss could lead to cortical re-allocation, de-afferentation, or 
atrophy to support speech perception processing. This reorganization can be to 
the detriment of general cognitive performance, adding to existing brain 
pathology (e.g., amyloid burden, neuronal loss) by altering critical brain regions 
which could otherwise be utilized for higher-level cognitive processing.  
Prolonged sensory deprivation from peripheral hearing loss may lead to changes 
and decreases in cortical brain volume similar to that seen with cognitive 
decline63-64. In particular, changes to temporal lobe volume and reduced gray 
matter density have been noted in those with peripheral hearing loss59, 65-66. 
These are brain regions important for semantic memory and involved in 
progression along the dementia continuum. Brain regions affected include the 
superior temporal gyrus and Heschel’s gyrus as well as frontal and pre-frontal 
brain regions67. Reduced whole-brain gray matter volume is significantly 
associated with brain regions recruited for speech understanding, including the 
frontal cortex and hippocampus68. Evidence indicates hearing loss is associated 
with lower white matter microstructural integrity in brain regions critical for 




Critical ages or length of sensory deprivation necessary to evoke these structural 
changes remains to be characterized. Even in early stages of cognitive 
impairment, cortical reorganization due to age-related hearing loss is apparent72-
73, however the degree of reorganization necessary to evoke brain atrophy and 
changes to cognitive performance has not been determined. This research 
suggests prolonged sensory deprivation may lead to a reduction in cortical 
volume beyond that seen from dementia pathology alone or may necessitate 
reorganization due to prolonged deprivation. This additional structural and 
functional decline results in further restriction of cortical capacity available for 
cognitive processing.  
2.4.2 Information Degradation Hypothesis 
In contrast to the physical nature of the association between age-related 
hearing loss and cognitive decline posed by the sensory deprivation hypothesis, 
the information degradation hypothesis proposes that the association is due to 
the increased cognitive processing required to compensate for an impoverished 
sensory input. This increased processing for degraded perception draws on the 
same resources needed for other higher-level cognitive processing and semantic 
encoding74. The subsequent increased cognitive demands required to accurately 
encode information takes extensive listening effort with particular demands on 
attention, memory, and executive function74-77.  The cognitive capacity of an 
individual and ability to compensate for decreased cognitive performance varies 
and may partially explain some of the variance between existing brain pathology 




effort required with hearing impairment may increase the cognitive load and the 
full demands placed on the brain at any time78. These demands then draw on the 
compensatory buffering ability of the individual, potentially resulting in the earlier 
presentation of clinical symptoms and dementia.  
Additionally, differences between compensatory mechanisms activated for 
cognitive performance between older and younger adults with sensory deficits is 
evident and may highlight increased fatigue in older adults for the dual tasks of 
listening and understanding79. Thus, this hypothesis implies temporary cognitive 
impairment. Through the amelioration of auditory input, cognitive performance on 
higher-level tasks might be restored. 
2.4.3 Common Cause 
The association between hearing and cognition in older adults could also 
simply stem from the same underlying mechanism, resulting in both 
impairments61-62. Investigation of a common cause associated with both hearing 
and cognitive impairment has been primarily evaluated through PTA due to the 
presumed independent effect of peripheral hearing. General neural degeneration 
commonly seen with aging could potentially result in decreased cognitive function 
and auditory performance61,80. Age associated slowing of processing speed may 
result in slower overall cognitive functioning as well as slower processing for 
sensory integration and perception10,33. Concurrent changes in both cognitive 
and sensory modalities in older adults could also stem from conditions such as 
cerebrovascular disease1,81-82. Systemic vascular pathology impacting the spiral 




potentially alter both auditory and neural functioning. Investigation into an 
underlying common genetic risk between AD and hearing loss suggests genetic 
risk for AD (as represented by a weighted sum of identified polymorphisms for 
AD and the inflammatory pathway) is associated with poorer speech-in-noise 
performance and self-reported difficulty hearing with background noise83. 
However, question of causality in this association between shared genes 
remains84 as the number of studies investigating genetic risk are limited, 
warranting further investigation.  
2.4.4 Other Potential Factors in the Association between Hearing and 
Cognition 
The association of hearing and cognition may also be mediated through 
other potential risk factors for dementia, including social isolation, depression, or 
decreased physical activity. Social isolation and loneliness as a consequence of 
hearing loss is not a new concept, nor is the idea that decreased social 
interaction increases risk of dementia85-88. While evidence is mixed, hearing loss 
may lead to increased risk of depression in older adults, which has been 
considered either a prodromal symptom or an independent risk factor for 
cognitive decline (see also for review Rutherford et al 2018). Further, hearing 
loss may lead to reduced physical activity due to anxiety from decreased auditory 
awareness89-90. Additional work suggests hearing loss is associated with 
increased prevalence of frailty among older adults which has been suggested to 




context of the above hypothesis remains to be clarified, yet each offers 
opportunity for targeted intervention.  
2.4.5 Summary of Proposed Hypotheses and Mechanisms 
It is likely that one or more of the proposed mechanisms explain and/or 
mediate the association between hearing loss and dementia. The specific 
contribution of each proposed mechanism toward risk of dementia may vary 
individually. While common risk factors (i.e., age, education, vascular disease) 
are thought to contribute towards the association35,61,93, these factors likely do 
not explain the full story. In epidemiologic studies which have attempted to 
control for these confounding factors as best as able, the association persists, 
potentially indicating that other mechanisms are likely involved.  
2.5 Priorities for Future Research 
Given the wide multi-disciplinary scope of research on hearing and 
dementia, identification of research priorities can help propel the field of auditory 
science toward meaningful advances in both hearing and dementia care. A 
foundational objective is identifying subgroups of individuals who may be at a 
greater risk of cognitive decline or may benefit most from intervention.  Many 
crucial research questions and additional perspectives exist [Wayne & Johnsrude 
(2015), Whitson et al (2018)]. Here we highlight three areas of research priorities 
which we believe will provide the greatest advancements in understanding the 
association and possible causal role of hearing impairment along the dementia 




standardized use of validated measurement tools for the assessment of hearing 
and cognition in older adults, and 3) evaluating the efficacy/effectiveness of 
interventions to treat hearing impairment to delay the onset of dementia (Figure 
2.4).  
2.5.1 What is the driving mechanism behind the hearing-cognition 
association? 
If we can determine the link(s) or driver(s) behind the association of 
hearing loss with cognition, we may better plan for and provide appropriate 
intervention options to delay the onset or alter the trajectory of the clinical course 
of dementia.  How best to intervene, and ultimately whether treatment for hearing 
loss will be effective in decreasing or delaying dementia risk, largely depends on 
the underlying mechanism. Research has yet to determine if there is an 
independent effect of hearing loss on cognitive impairment for older adults. As 
described above, the relationship between AD pathology and the presentation of 
symptoms is heterogeneous. We do not yet know by what means hearing 
impairment may influence a potential buffer which delays/prevents the 
presentation of symptoms in some individuals yet leads to earlier 
symptomatology in others.  
If the association between hearing impairment and dementia was only due 
to a common cause of both hearing loss and dementia, such as vascular disease 
or genetics, the opportunity for directly preventing or changing the progression of 
dementia through treating hearing loss would be limited. In turn, research focus 




at hand which could have significant downstream effects on hearing and 
cognition for older adults.  
Both the sensory-deprivation and information degradation hypotheses 
imply a more direct effect of hearing impairment on dementia risk. While the long-
term vs short-term timeline of this effect varies by hypothesis, both suggest that 
hearing impairment leads to downstream effects on available cognitive 
resources.  However, the nature of the effect from either hypothesis has 
implications for approaches to intervention. With structural and functional 
changes in the brain due to hearing impairment via the sensory deprivation 
hypothesis, early identification of hearing impairment and options to potentially 
delay or prevent deafferentation or atrophy within the auditory or sensory regions 
of the brain are essential to prevent lasting structural damage. This hypothesis 
may further demonstrate treatment benefit at later stages of hearing impairment, 
for example, by delaying additional neural reorganization or atrophy. In contrast, 
the information degradation hypothesis would provide a strong argument for new 
and existing hearing intervention options at any stage of the disease process— 
with improved integrity of auditory input via rehabilitation or hearing treatment, 
the strain on cognitive resources for environmental awareness or communication 
would be reduced.  
Disentangling central auditory dysfunction and cognitive decline will be 
essential for targeting prevention efforts or early identification of subgroups at 
greater risk for cognitive decline. The temporality of the association and whether 




independent process, and how to differentiate the two, remains a challenge in 
understanding the link between hearing loss and dementia. The dependence of 
both peripheral and central hearing on higher-level, auditory-based cognitive 
functioning leaves significant questions of how to interpret the influence of each 
component along the auditory pathway. If central auditory dysfunction represents 
an early marker of dementia, how measures of CAD may fit within the context of 
existing early biomarkers of dementia or neuropsychiatric test batteries remains 
to be determined.  
In all likelihood, multiple mechanisms are involved in the hearing-dementia 
association; thus, further investigation should determine if one mechanism 
serves as a primary driver and how each might interact to alter risk. It is possible 
the primary driver is unique to the individual, allowing for a person-centered 
approach to intervention that alters the progression to dementia.  
2.5.2 How do we best measure hearing and dementia in this process? 
Data are only as good as the measurement tools used to collect them. If 
we are not able to effectively measure our construct of interest, then our data 
may not appropriately answer the question of interest. The majority of studies on 
hearing impairment and dementia or cognitive decline have focused on utilizing 
audiometry or self-reported hearing – yet these measures reflect two differing 
constructs for hearing impairment. While both measures reflect aspects of 
hearing function, understanding the primary research objective will determine the 
most effective measure. We need to identify what hearing measures (i.e., self-




auditory function measures) provide the best representation of the mechanisms 
driving the association. We should also identify the most practical and useful 
measure to estimate a causal effect or for detection of cognitive change in a 
clinical environment or population-based research study. Synthesis and 
harmonization of data are most effective and informative if less heterogeneous 
and streamlined types of measures are collected across a wide range of studies 
and represented populations. Because the auditory pathway encompasses both 
peripheral and central hearing components, effectively and efficiently discerning 
and utilizing these respective measures for study of cognition in older adults is 
imperative to progress in this research.  
There is need to disentangle the potential for sensory bias in cognitive 
testing and the dependence on cognitive functioning for auditory measures, 
particularly speech-in-noise measures. Cognitive tests and screening tools rely 
on an individual’s auditory or visual ability for completion. This dependence has 
led some to question if auditory or visual impairments may lead to potential 
sensory bias with cognitive tests94-95. Confirming the validity of the test within the 
cognitive domain and construct of interest is essential for use in the growing 
number of older adults with sensory impairments96. Among important questions 
to consider is whether accommodations during testing for individuals with hearing 
loss is appropriate. Cognitive tests which maintain integrity of the assessment but 
are simple and efficient for hearing impaired older adults, researchers, and 




to cognitive assessments will be important for confidence and synthesis of study 
results.  
2.5.3 Does treating hearing loss alter dementia risk? 
Evidence for the impact treating hearing impairment has on cognitive 
decline or dementia is accumulating. However, until the results of the current 
longer-term clinical trials are available, the evidence of these effects on cognitive 
decline and dementia risk largely stem from observational studies. There is great 
power in our insights gained from observational studies, however evidence of 
causality for decreased or delayed cognitive decline due to hearing aid use is 
more challenging. Challenges include selective effects of who chooses to pursue 
hearing aids as well as heterogeneity in device, fitting, use, temporality, or 
unmeasured confounding.  Not only must we still determine if treating hearing 
loss using hearing aids attenuates dementia risk or delays presentation, we also 
have a limited understanding of how and when to best intervene.  
Public health prevention strategies recognize the potential for targeted 
intervention at each stage of the disease process— known as primary, 
secondary, and tertiary prevention50 (Figure 2.5). Evidence for hearing 
intervention at these levels of prevention remains limited, and an understanding 
of how hearing loss treatment throughout the process might influence upstream 
higher-level cognitive processing is virtually non-existent. Determining the best 
choices for prevention within a population is dependent on evidence of efficacy, 
effectiveness, and cost efficiency— all areas with extensive gaps in evidence for 




Primary prevention strategies involve the reduction of risk factors before 
the disease process begins50. In this association, primary prevention focuses on 
reducing the onset of cognitive decline among those with cognitive abilities with 
that expected for age and background. Early identification of hearing loss and 
adoption of hearing treatment may prevent structural changes in the brain 
(sensory deprivation hypothesis) thereby reducing the additional ‘hit’ to cortical 
structures and demands on neural allocation. Key objectives of hearing aid 
clinical trials are to determine if adoption of hearing aids for hearing impairment 
(at least peripheral hearing impairment) may delay progression of cognitive 
decline and how the use of amplification may therefore influence the outcome.  
Secondary prevention involves the early detection and prevention of 
disease through screening and early identification, and encompasses 
intervention upon those at clear risk of progression of cognitive impairment. 
Identification of hearing impaired older adults with concurrent mild cognitive 
impairment, subjective cognitive complaints, or significant biomarkers of 
dementia are the focus of these efforts. Delay of further cognitive decline and 
transition to dementia through amplification use, aural rehabilitation and 
communication strategies would make a lasting contribution to dementia 
prevention. 
The last stage of prevention, tertiary prevention, in this case follows the 
onset of dementia and focuses on supportive and rehabilitative services to 
minimize morbidity and mortality or maximize quality of life. The use of hearing 




pathway by reducing social isolation or depression risk for older adults, which 
can worsen dementia symptom trajectories. Importantly, neuropsychiatric (i.e. 
depression, agitation, anxiety, delusions, aggression, apathy etc.) symptoms are 
fairly common at all stages of dementia and are associated with poor outcomes 
for both patients and caregivers97.  However, hearing aid use has been 
associated with fewer and lower severity neuropsychiatric symptoms and less 
severe depressive symptoms in older adults with cognitive impairment98. 
Therefore, not only does hearing aid use among ADRD patients demonstrate 
improved communication, decreased hearing handicap, and improved quality of 
life47, 99-100, it may also reduce common dementia-related behaviors detrimental 
for individuals and challenging for caregivers and providers. 
Within tertiary prevention, we must further determine how to provide 
auditory rehabilitation for adults with cognitive impairment101. While current 
evidence suggests treating hearing loss in cognitively impaired older adults yields 
benefits as described above, the strength of the evidence is limited due to its 
case-report and subjective nature. Determining alternative accessible and 
effective means of hearing rehabilitation for cognitively impaired and aging adults 
is imperative to meeting future population needs. Even with changes in health 
policy improving access to hearing care and rehabilitation, hearing aids may not 
be feasible for some older adults and likely do not meet the listening needs of 
many adults when used as the only form of rehabilitation. Alternative strategies 




determine if these approaches better meet the auditory and cognitive needs for 
some older adults.   
2.6 Utilizing current and future evidence to improve patient care 
How auditory scientists, cognitive scientists, epidemiologists, and other 
investigators present the research on hearing and cognitive impairment can have 
significant implications for how clinical providers educate patients and their 
families. Epidemiologic studies comprise much of the research on hearing and 
cognitive impairment in older adults. These studies are primarily observational, 
conducted using population-level data. This design allows for the observation of 
health-related trends within a selected population of individuals. Thus, on 
average, observation of a significant positive association in epidemiologic data 
suggests those with hearing impairment demonstrate an increased risk of 
cognitive impairment compared to those with normal hearing. This type of data 
does not imply that a given individual with hearing impairment will go on to 
develop dementia, but helps identify groups of individuals whom primary care 
providers may wish to monitor for cognitive change. 
In comparison, some of the work by cognitive and auditory researchers 
has been conducted within selective and controlled clinical or research 
environments. These environments allow for ease of participant recruitment and 
control of variables, yet the use of clinic-based populations does not necessarily 
ensure that the complex relationship between hearing ability and cognitive 
impairment seen within the broader real world is captured. Many clinic- or 




to participate in studies, and participants often possess characteristics which may 
not be generalizable or representative of the general population or under-
represented groups. Thus, while epidemiologic cohorts also have their 
limitations, understanding trends within a population helps identify areas of 
further research. These population trends inform health program planning, health 
policies, and identification of areas for targeted research. Each research 
environment presents differing angles or perspectives with which scientists may 
address research needs, enriching collaborations and our comprehensive 
approach to the public health issue. 
Given the varied disciplines involved in research on hearing and cognitive 
impairment, understanding how to synthesize the current evidence, translate 
findings, and guide future research for scientific progression is vital. However, 
current research has primarily remained siloed within disciplines. Auditory 
science and cognitive science researchers have the opportunity and expertise to 
address aspects of the primary research gaps described above. Transparency of 
and careful consideration of study design, measurement tools implemented, and 
discussion of results’ applicability for clinical or community populations is 
essential to characterize the role of hearing impairment within the dementia 
timeline and meet the needs of our current and future older adults.  
2.7 Conclusion 
While research on the contribution of age-related hearing loss to dementia 
risk has been around for decades, growing evidence of the adverse 




hearing health and care into the clinical exam room and to the attention of older 
adults and policy makers. The human and economic expense of caring for the 
coming wave of adults reaching or past retirement age demands interdisciplinary 
collaboration. Auditory science has the opportunity to contribute towards efforts 
to reduce this impact. Identification of the mechanism(s) driving the association 
between hearing and dementia, directed hearing-dementia research for the 
greatest public health impact and societal needs, and thoughtful translation of 
this research for clinicians and patients can have a monumental impact on 
prevention and intervention strategies for older adults. The interdependent and 
synergistic processes of hearing and cognition require careful approach. 
Optimizing our strategies to treat hearing loss could diminish the risk of adverse 
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FIGURE 2.1 Estimated and Projected Trends in Prevalence of Hearing loss 
(mild hearing loss and moderate or greater hearing loss) and Dementia in 
older adults by age categories in the United States from 2020 to 2050.   
  FIGURE 2.1 Data compiled from Goman et al. 2017 and the Alzheimer’s Disease Facts 





FIGURE 2.2 Conceptual Model of cognitive trajectory along the cognitive 
















FIGURE 2.2 This continuum represents a departure from normal aging with decreased cognitive 
ability greater than expected with normal aging (green region). Mild Cognitive Impairment (MCI) 
diagnosis may be provided with a change in cognition with minimal functional loss (orange 
region). Dementia diagnosis may be provided with further progression with cognitive impairment 





FIGURE 2.3 Hypothesized framework for the mechanism of the hearing and 













FIGURE 2.3 The center blue circle includes potential causal paths between peripheral hearing loss and 
cognitive decline or dementia, including changes to brain structure and function (i.e., sensory deprivation 
hypothesis), increased cognitive demands (i.e., information degradation hypothesis), and other effects such as 
social isolation. Additionally, a common cause such as systemic vascular disease or genetic factors may lead 
to both peripheral hearing loss and cognitive decline and dementia. Further inclusion of central auditory 
function as a result of direct and indirect effects from this causal pathway and may serve as a marker of 
cognitive decline or dementia. It is likely more than one of the pathways depicted may explain the link 





FIGURE 2.4 Key Research Gaps in Hearing Impairment and Cognition. 
  
FIGURE 2.4 Targeted research on the mechanism behind the association between hearing and 
cognition will guide intervention and prevention strategies. Additional research gaps include 
careful study and identification of the most appropriate and efficient auditory measure for 
association and causal effect studies of hearing and cognition, as well as ensuring fidelity of 
cognitive tests with hearing impairment. Further understanding of if treating hearing loss via 





FIGURE 2.5 Schematic of levels for dementia prevention through 
identification of and management of hearing loss in combination with the 





FIGURE 2.5 A) primary prevention focusing on the prevention of initial development 
of cognitive decline in normal cognitive aging B) secondary prevention focusing on 
early detection and intervention of preclinical dementia C) tertiary prevention with a 












CHAPTER 3: Hearing Loss and Risk of Depressive Symptoms in 









Background: Hearing loss (HL) is a highly prevalent condition among older 
adults and may lead to increased risk of depressive symptoms, yet has received 
little characterization by race and gender. In both cross-sectional and longitudinal 
analysis, we quantified the association between HL and depressive symptoms, 
incorporating the variable nature of depressive symptoms over time. 
Methods: Data were from the Health, Aging, and Body Composition (Health 
ABC) study, a racially diverse cohort of community-dwelling older adults’ age 70-
79 years. Depressive symptoms was defined using the Center for Epidemiologic 
Study Depression Scale short form (CES-D 10) and reported use of treatment for 
depression. Significant depressive symptoms was defined as CES-D 10 score 
≥10.  Hearing acuity was defined via pure-tone average in decibels hearing level 
(dB HL) in the better hearing ear at frequencies 500-4000 Hz, categorized as 
normal hearing (PTA<25 dB HL), mild HL (PTA 25-40 dB HL), and ≥moderate HL 
(PTA >40 dB HL). Associations between hearing status and baseline depressive 
symptoms were quantified using logistic regression, with incident depressive 
symptoms using Cox proportional hazard models, and with change in depressive 
symptoms over time using generalized mixture models and multinomial logistic 
regression. 
Results: Among 2,089 older adults (1,082 women, 793 Black), 793 had a mild 
hearing loss and 435 had a moderate or greater HL. At baseline, a moderate or 




(OR: 2.45, 95% CI: 1.33, 145), with notably higher odds among women and 
Black participants. Higher risk for incident depressive symptoms was observed in 
the overall sample (HR: 1.26 95% CI: 1.00, 1.58). We identified three depressive 
symptom trajectory patterns: low, moderate increasing, and borderline high 
depressive symptom levels from growth mixture models. Moderate or greater HL 
was more prevalent in the borderline high depressive-symptom trajectory class 
compared to the low depressive symptom trajectory class (RRR 1.16, 95% CI: 
1.01, 1.32). A poorer depressive symptom trajectory was more common among 
Black participants and less common among White participants, regardless of 
hearing status. 
Conclusion: HL was associated with greater depressive symptom, particularly 
among women and Black participants. Investigation of psychosocial factors 
related to this risk and potential amelioration by hearing aid use could have 








3.1 INTRODUCTION  
Two-thirds of adults over the age of 70 years have a hearing loss, with 
prevalence rising for each additional decade of life1. While traditionally viewed as 
primarily impacting communication, increasing evidence indicates hearing loss 
may lead to adverse psychosocial effects, including depression or depressive 
symptoms2-4. Older adults with hearing loss may avoid social situations or have 
difficulty engaging with surroundings and loved ones due to difficulty 
communicating in challenging listening situations. Further, changes in brain 
structure due to hearing loss may lead to increased vulnerability for depressive 
symptomatology or result in behaviors which can increase social isolation and 
risk for depression5. Recent hypotheses suggest the psychosocial impact of 
hearing loss may differ not only by environment and listening needs, but also by 
race and gender5-7. With the high prevalence of hearing loss in older adults, 
understanding how hearing loss influences risk of depression, and potential 
differences presented across race and gender, may aid in the identification of 
those at higher risk for late-life depression.  
Prior studies have demonstrated a range of associations suggesting 
hearing loss is independently associated with depressive symptoms in older 
adults, yet there are discrepancies in previous findings8-13. To date, longitudinal 
evaluations of hearing and depression are limited9-11. However, the presence of 
depressive symptoms is commonly influenced by life events, placing an 




prolonged increased levels of depressive symptoms may further increase risk for 
cognitive outcomes like dementia. Recent work in the Health, Aging, and Body 
Composition Study11 investigated the association of self-reported hearing status 
on trajectories of depressive symptom change over 10 years. Results suggest 
baseline impaired hearing was associated with a greater odds of a trajectory of 
increasing depressive symptomatology and of persistently high depressive 
symptoms, compared to a group characterized by low depressive symptom 
trajectories.  
The ability to communicate effectively with others includes not only 
measured hearing ability, but also influences from a person’s social, 
psychosocial, and life circumstances. Therefore, aspects of one’s socially defined 
race and gender may present different influences on risk of depression by 
hearing status as race and gender additionally include social, socioeconomic and 
cultural influences. Specifically, among women, prior work has shown women 
place a greater emphasis on network with friends and family and emotional 
intimacy than men, actions which have demonstrated protection against 
depressive symptoms but which may be adversely impacted by hearing loss14. 
Moreover, the psychosocial stress from inclusion in a marginalized group among 
Black individuals has been well documented15-17. This prolonged psychosocial 
stress has been linked to increased risk for depressive symptoms17 and may be 
exacerbated further among hearing impaired Black older adults and might 




Our study aims to expand upon prior work with cross-sectional and 
longitudinal investigation of the association between audiometrically-assessed 
hearing loss and depressive symptoms, overall and by race and gender. We aim 
to investigate the degree to which hearing loss is associated with greater 
prevalence of depressive symptoms, greater incidence of depressive symptoms, 
or a greater increase in depressive symptoms over time. We leveraged data from 
the Health, Aging, and Body Composition Study (Health ABC). We hypothesize 
hearing loss is associated with greater risk for the presence and new occurrence 
of depressive symptoms, as well as larger changes in severity of depressive 
symptoms, particularly among women and Black participants.  
 
3.2 METHODS 
3.2.1 Study Population 
Participants were enrolled in the Health ABC study, a prospective study of 
3,075 well-functioning, community-dwelling Black and White older men and 
women aged 70-79 years recruited in 1997-1998 from Pittsburgh, Pennsylvania 
and Memphis, Tennessee18. Participants were selected for inclusion in this study 
if they reported no difficulty walking ¼ mile or climbing up 10 steps. Follow-up 
consisted of yearly clinical examinations and 6-month interim phone calls, 
terminating in 2013. Audiometry was conducted at the study visit during the 5th 
year of follow-up. This study was approved by the Institutional Review Boards of 




Participants were excluded if: 1) they did not attend the year 5 clinical visit 
when audiometric testing was performed (n=779); 2) had incomplete audiometric 
data (n=93); 3) were missing covariates (n=99); or 4) were missing baseline 
CES-D scores or reported a history of treatment for depression (n=15), leading to 
a final analytic sample of 2,089 participants. Analyses of the rate of longitudinal 
change of depressive symptoms further excluded those with fewer than two 
completed measures of CES-D 10 (n=1). Additionally, for the longitudinal 
investigation of incident depression, those with high depressive symptoms at 
baseline (CES-D 10 ≥ 10 at baseline; n=111) were excluded.  
 
3.2.2 Measures 
3.2.2.a Assessment of Depression and Depressive symptoms 
A comprehensive assessment of depression was obtained using multiple 
measures. A history of self-reported treatment for depression or history of 
antidepressant use intended for depression was assessed at baseline. Further, 
the standard 20-item Center for Epidemiological Studies Depression Scale 
([CES-D; years 1, 4, 6, 8, 10, and 11) or the abbreviated 10-item ([CES-D 10]; 
years 3 and 5) was administered to participants, allowing for up to 10 years of 
follow-up of depressive symptoms. Incident reported treatment for depression or 
reported antidepressant medication use intended for treatment of depression was 
collected during initial follow-up (years 2, 3, 5 and 6). To allow for maximum 
comparability across years of follow-up, scores on the 20-item CESD were 




1994). Scores ≥10 on the CES-D 10 have been shown to be highly sensitive in 
identifying participants correctly with significant depressive symptoms19-20. At 
baseline, prevalent depressive symptoms was defined as a score on the CES-D 
10 of ≥ 10 or self-reported current treatment for depression. Incident depressive 
symptoms was defined as a change in CES-D 10 scores to a score ≥ 10 from a 
score of <10 or reported incident treatment for depression between years 2-11. 
Baseline for incident depressive symptoms was defined as year 1 (baseline) of 
the study. 
3.2.2.b Hearing Measures  
Audiometry was performed four years after baseline enrollment at Visit 5 
(2001-2002). Air-conduction thresholds were obtained for each ear at 500, 1000, 
2000, 4000, and 8000 Hz in a sound proof booth using an audiometer (Maico 
MA40) and supra-aural earphones (TDH 39). A speech-frequency pure tone 
average (PTA) of hearing thresholds obtained at 500-4000 Hz was calculated for 
the better hearing ear. Hearing loss was evaluated continuously in dB HL and 
categorized based on clinically defined cut points by threshold of response (no 
hearing loss: <25 dB HL; mild impairment: 25-40 dB HL; moderate or greater 
impairment > 40 dB HL). In secondary analysis, we investigated if hearing aid 
use attenuated the influence of hearing loss on prevalent or incident clinically 
significant depressive symptoms. Hearing aid use was ascertained via self-report 





3.2.2.c Other Covariates  
Demographic information collected at baseline (year 1) included age, 
gender (categorized by sex classification assigned at birth, men vs women), race 
(Black vs White), education (less than high school, high school, or post-
secondary education), marital status (never married, married, 
widowed/divorced/separated), living alone, and study site (Memphis vs 
Pittsburgh). Health-related factors were treated as time fixed and included history 
of smoking (never, former, current), cardiovascular disease history (systolic blood 
pressure ≥140 mm Hg, diastolic blood pressure >90 mmHg; reported history of 
stroke), and type 2 diabetes mellitus (use of diabetes drugs, fasting glucose ≥ 
120 mg/dL) as assessed at baseline.  
3.2.3 Statistical Analyses 
Baseline characteristics were compared using the Wilcoxon rank-sum and 
Fisher’s exact tests where appropriate and evaluated within each hearing 
category. The association between hearing and depressive symptoms was 
modeled both cross-sectionally and in complementary longitudinal analysis. 
3.2.3.a Prevalence of depressive symptoms at baseline 
We investigated differences in the prevalence of depressive symptoms 
and current treatment for depression by category of hearing loss at baseline 
using logistic regression. Models were adjusted for demographic and health 
factors. All analyses were further stratified by race and gender to investigate 
potential modification of risk. As a previous history of depressive episode is 




also adjusted for history of depression prior to baseline as well as hearing aid 
use.  
3.2.3.b Incident significant depressive symptoms or reported treatment 
for depression 
The association between hearing loss and incident significant depressive 
symptoms was modeled using discrete time proportional hazard models among 
those with CES-D 10 scores <10 at baseline and not reporting current treatment 
for depression. The assumption of proportionality was verified using Schoenfeld 
residuals21. Year 1 was used as the time origin. Individuals had an event once 
they reported initiation of treatment or medication use intended for depression, or 
first CES-D 10 score ≥ 10. Participants were censored at the first missing 
observation. History of self-reported treatment for depression was adjusted for by 
inclusion in the baseline hazard function, as was age, education, gender, and 
race. In secondary analyses, models were stratified by race and gender to 
investigate potential modification of risk. Sensitivity analyses further adjusted for 
reported history of depression at baseline. 
3.2.3.c Change in depressive symptoms over time 
We characterized change in depressive symptoms over time using a 
group-based trajectory modeling approach.  Trajectories of depressive symptoms 
were evaluated over the first 8 years of follow-up using growth mixture models 
(GMM), a form of trajectory modeling which models individual variation in distinct 
developmental paths over time as distinct classes defined by levels and 




and accommodates individual heterogeneity within each identified subgroup22-24. 
Mean trajectories of CES-D 10 scores were estimated in the full base analytic 
sample of 2,089 adults using MPlus 8.025 (years 1, 3, 5, 6, 8). Years of CES-D 10 
were selected to include the years of richest depressive symptom data and 
include measures around when audiometric testing was performed. We used a 
maximum likelihood estimator and freely estimated within class variances. We 
determined the of number of trajectory classes based on recommended 
procedures24, using measures of AIC, BIC, Bootstrapped likelihood ratio test, and 
the Lo, Mendell, Rubin likelihood ratio test. Based on these procedures 
(Appendix A.1), the best fitting model included 3 trajectories of depressive 
symptoms which was used in subsequent analyses. One class was characterized 
by low trajectory pattern, a second class by moderate increasing trajectory 
pattern, and a third class by a borderline high trajectory pattern.  
  To investigate if hearing loss is associated with latent class membership 
of depressive symptom trajectories, we used multinomial logistic regression, 
estimating the relative risk ratio of depressive symptom trajectory by hearing 
status from baseline to year 10, with normal hearing as the reference category. 
Models were adjusted for demographics and health factors as well as 
antidepressant medication use, as use of antidepressant medication may 
influence performance on the CES-D 10. Those who self-reported antidepressant 
medication use but no history of depressive symptoms or current treatment for 
depression were not included in the analysis. All analyses were again stratified 




Significance testing for all analyses was conducted using 2-sided tests 
(type I error rate=0.05). Logistic, discrete time proportional hazard, and 
multinomial logistic regression models were performed using STATA version 15 
(StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: 
StataCorp LP).  
 
3.3 RESULTS 
3.3.1 Demographic and clinical characteristics 
Of the 2,089 participants included in our prevalence analysis at baseline, 
861 (41.2%) had normal hearing, 793 (38.0%) had a mild hearing loss, and 435 
(20.8%) had a moderate or greater hearing loss, 182 (8.7%) reported a history of 
depression at baseline, 79 (8.3%) had clinically significant depressive symptoms 
or indicated current treatment for depression at baseline, and 89 (4.5%) had 
incident significant depressive symptoms during 10 years of follow-up. The mean 
CES-D 10 score at baseline was 2.9 (SD: 3.3). Demographic characteristics by 
hearing category are in Table 3.1. Those with normal hearing were more likely to 
be younger, women, Black participants, and have a higher education level than 
those with hearing loss. Participant characteristics did not differ by baseline 
diabetes, living alone, baseline history of hypertension, or baseline history of 




3.3.2 Prevalence of depressive symptoms at baseline 
Compared to normal hearing, those with a moderate or greater hearing 
loss experienced 2.45 times the odds (OR: 2.45, 95% CI: 1.33, 4.51) of clinically 
significant depressive symptoms; mild hearing loss was associated with 1.38 
times greater odds (OR: 1.38, 95% CI: 0.78, 2.43) of significant depressive 
symptoms (Table 3.2). A significant dose-response association was observed 
with greater odds of depressive symptoms with increasing level of hearing loss 
(p=0.004).  
In stratified analyses, women and Black participants with hearing loss 
demonstrated higher odds of significant depressive symptoms compared to those 
with normal hearing, again demonstrating a significant dose-response 
association (p for trend:0.009 women, 0.013 Black); although these differences 
by gender and race were not statistically significant, they are remarkable for their 
potential public health implications. Among women, compared to participants with 
normal hearing, those with moderate or greater hearing loss had 2.89 times the 
odds of clinically meaningful depressive symptoms (OR: 2.89, 95% CI: 1.30, 
6.43); those with mild hearing loss had 1.7 times greater odds (OR 1.70, 95% CI: 
0.83, 3.47). Results among men were higher for those with a moderate or greater 
hearing loss (OR: 1.81, 95% CI: 0.69, 4.72), but not mild (mild hearing loss: OR: 
0.92, 95% CI: 0.35, 2.44) compared to normal hearing. Black participants with 
moderate or greater hearing loss or mild hearing loss demonstrated over 3 times 
(OR: 3.35, 95% CI 1.25, 9.01) or over 2 times (OR: 2.24, 0.93, 5.42) greater odds 




hearing, respectively. In analysis restricted to White participants, the odds of 
significant depressive symptoms for those with a moderate or greater hearing 
loss was 1.84 (OR: 1.84, 95% CI: 0.85, 3.96) with no observed difference for 
those with mild hearing loss (OR: 0.96, 95% CI: 1.84, 95% CI 2.06) compared to 
participants with normal hearing. The width of the confidence intervals in our 
stratified analyses prevent definitive conclusions on the associations. P-values 
did not support a difference in prevalence of depressive symptoms by race and 
gender. 
Results were similar in a sensitivity analyses adjusting for reported history 
of treatment for depression at baseline and antidepressant use without reported 
treatment for depression. Secondary exploration of hearing aid use demonstrated 
no overall association with prevalent depressive symptoms at baseline. 
3.3.3 Incidence of significant depressive symptoms by hearing status over 
10 years of follow-up 
Hearing loss was associated with a greater hazard for incident depression 
(CES-D 10 ≥ 10) for those with a moderate or greater hearing loss compared to 
normal hearing in the overall sample (HR: 1.26, 95% CI: 1.00, 1.58) after 
accounting for demographic and health factors as summarized in Table 3.3. We 
did not find significant differences in the association between hearing status and 
incident dementia by race or gender.  
Results remained consistent after adjustment for history of treatment for 
depression at baseline. Self-reported hearing aid use at baseline demonstrated 




3.3.4 Change in depressive symptoms over time by hearing status 
We identified three depressive symptom trajectory patterns: low, moderate 
increasing, and borderline high depressive symptom levels (Figure 3.1). Among 
the 2,088 participants included in the baseline analytic cohort, 1390 (66.6%) had 
low levels of depressive symptoms, 566 (27.1%) had moderate increasing 
symptoms, and 132 (6.3%) had borderline high or high symptom levels based on 
CESD-10 scores. The mean posterior probabilities for group membership for 
each trajectory are 0.967 for low, 0.832 for moderate increasing, and 0.866 for 
borderline high, suggesting strong classification quality.  
Multinomial logistic regression results (Table 3.4) suggest an increased 
relative risk of borderline high depressive symptom trajectory compared to low 
depressive symptom trajectory for those with moderate or greater hearing loss 
compared to normal hearing. In models adjusted for demographics, health 
factors and antidepressant medication use, the relative risk of a borderline high 
depression trajectory compared to low trajectory was 1.16 (95% CI: 1.01, 1.32) 
for moderate or greater hearing loss compared to normal hearing and borderline 
significant at 1.06 (95% CI: 0.95, 1.18) for those with mild hearing loss compared 
to normal hearing. Results from the overall sample were marginally significant 
indicating the relative risk for a moderate increasing depressive symptom 
trajectory compared to low trajectory was 0.91 (95% CI: 0.84, 0.98) for mild 
hearing loss and 0.96 (95% CI: 0.87, 1.05) for moderate or greater hearing loss 




In stratified analysis, a greater relative risk of borderline high depressive 
symptom trajectory was noted among women and among Black participants, 
while a lower risk of inclusion in the moderate increasing class compared to low 
trajectory was observed for White participants. Effect modification by race was 
significant for this analysis (p=0.002). Among women with moderate or greater 
hearing loss a 1.25 (95% CI: 1.03, 1.52) greater relative risk of borderline high 
trajectory vs low trajectory was noted, compared to those with normal hearing, 
but no significant differences were observed for mild loss compared to normal 
hearing. Among Black participants, a relative risk of a borderline high depressive 
symptom trajectory was 1.24 (1.24, 95%CI: 1.04, 1.48 moderate loss) and 1.58 
(1.58, 95%CI: 1.24, 2.03 mild loss) compared to low trajectory. A lower relative 
risk was observed for a moderate increasing trajectory compared to the low 
trajectory class among White participants with any hearing loss compared to 
normal hearing, but no difference was noted for borderline high trajectory 
compared to low for either category of hearing loss among White participants. As 
before, the width of the confidence intervals in our stratified analysis limits 
conclusions in the associations by gender. P-values suggested a difference in 
the association of trajectory class by race (p=0.002 borderline high trajectory; 
p=0.001 moderate increasing trajectory). 
 
3.4 DISCUSSION 
In this demographically diverse population-based cohort of 2,089 older 




impact of hearing loss on depressive symptoms using a comprehensive definition 
of depression which incorporates self-reported history of depression, medication 
use, and questionnaires. Those with hearing loss demonstrated significantly 
greater odds of clinically significant depressive symptoms at baseline and 
suggest greater risk for incident clinically significant depressive symptoms over 
follow-up. Results were robust even after covariate adjustment and consideration 
of a history of treatment for depression. Analysis of depressive symptoms over 
time suggest greater risk for a poorer depressive symptom trajectory for those 
with hearing loss, particularly moderate or greater loss, compared to those with 
normal hearing. Estimates were higher among women and among Black 
participants in both baseline prevalence and investigation of change in 
depressive symptoms over time.  
Our results are consistent with the preceding work by Brewster et al11 
which demonstrated a cross-sectional association between low and mid-
frequency hearing status and depressive symptoms on CES-D 10 scores at year 
5 of the Health ABC study. Moreover, that work suggested 1.63 times the odds of 
an increasing depressive symptom trajectory and 1.85 times the odds of a 
consistently high depressive symptom trajectory for those reporting any age-
related hearing loss compared to those reporting no hearing loss. This prior work 
uniquely accounted for the complex nature of late-life depression by capitalizing 
on the longitudinal depression measures in HABC and incorporating a measure 
of depressive symptom trajectory over time. With expansion on this prior work, 




in addition to conducting stratified analyses to investigate potential differences in 
these associations by race and gender. Cacciatore et al26, suggested a positive 
relationship (r=0.85) between older adults with hearing difficulty and depressive 
symptom scores.  A meta-analysis27 including studies of chronic diseases and 
risk for depression in old age reported a pooled odds ratio of 1.71 for the odds of 
prevalent depression among those with poor hearing (not defined by the authors) 
and a pooled relative risk of 1.92 for incident depression among those with poor 
hearing compared to normal. An additional study from the Health ABC cohort by 
Contrera et al28 observed that compared to those with normal hearing, older 
adults with moderate or greater hearing loss demonstrated a 28% decreased 
odds of emotional vitality defined as a high sense of personal mastery, and high 
levels of happiness, and lower levels of depressive symptoms or anxiety.  
While consistent with these previous findings, our analysis undertook a 
more comprehensive approach to characterize the association in both cross-
sectional and longitudinal models using an established and validated 
questionnaire for depression. We observe significant associations between 
hearing loss and depressive symptomatology at baseline. The severity of 
depressive symptoms at the start of follow-up seemed to make a large 
contribution towards symptomatology measured. Even our classification of 
depressive symptom trajectory was dependent upon the degree of depressive 
symptoms at baseline, even after adjustment for history of depression. Longer 




sensitive periods for development of depression among hearing impaired older 
adults.  
Differences in the relationship between hearing impairment and 
depressive symptomatology by race and gender may potentially highlight the 
interconnected relationship between influences of social structure, 
communication ability, and depressive symptomatology for older adults. Prior 
evidence has suggested differences in late-life depression by gender and 
race17,29-31 yet few, if any, prior studies have attempted to quantify the association 
between hearing loss and depression by gender or race. While our analyses do 
not support an interaction between hearing loss and race or hearing loss and 
gender, we did observe differences in the magnitude of associations. A higher 
association between hearing loss and prevalent depressive symptoms, and 
overall poorer depressive symptom trajectory was observed among Black 
participants with a moderate or greater hearing loss vs normal over 10 years of 
follow-up than estimates observed among Whites. Similarly, a poorer depressive 
symptom trajectory was observed among women with a moderate or greater 
hearing loss. In contrast, among White participants with hearing loss compared 
to those with normal hearing, a lower risk of being in the moderate increasing 
trajectory compared to the low depressive symptom trajectory was observed, 
even after accounting for other demographic factors.  
Our use of several methods to represent the phenomenology of 
depression helps to better encapsulate the complex presentation of depression in 




to younger adults32, it is possible even one episode of depression is associated 
with significant negative outcomes (i.e., dementia, increased mortality, slower 
medical recoveries, increased disability)32-33. Late-life depression often has a 
differing presentation than depression at younger ages which warrants greater 
understanding for potential intervention34. Older adults are more likely than 
younger adults to endorse loss of interest in life or activities or express somatic 
symptoms32. While much remains in the identification of risk factors for late-life 
depression in older adults, a complex relationship between biological changes 
and vulnerabilities, stressful events, curtailment of daily activities, and self-
criticism may predispose an older adult to depressive symptoms5, 31-32. Hearing 
loss may therefore increase risk for late-life depression as a result of withdrawing 
from social activities and reduced engagement from difficulty communicating. 
Hearing impaired older adults may also become discouraged by their inability to 
have quality connections with others leading to downstream psychosocial effects 
like social isolation, loneliness, and depression. A biological basis with brain 
changes associated with hearing loss has been hypothesized as a mechanism 
for the association and warrants further study5. Even with the modest increased 
risk demonstrated in our analysis, consideration of hearing loss as a risk factor 
for depression is notable owing to the high prevalence of hearing loss and its 
potential treatability with hearing aids. Further characterization of how the 
intersectionality of race and gender (i.e., Black women, White women, Black 
men, and White men) among hearing impaired older adults may influence 




cope with hearing loss given life and social circumstances. Additionally, 
management of hearing loss has the potential to improve existing intervention 
strategies for late-life depression. The ability to maintain quality communication 
with managing physicians and adequately engage in intervention strategies like 
cognitive behavioral therapy or interpersonal therapy for late-life depression 
deserves further study but has the potential to supplement current management 
strategies. Reducing the clinical and social burden of late-life depression through 
aural rehabilitation and combined existing depression intervention strategies 
could have far-reaching incidental benefit. 
 Prior research on the effect of race and gender on late-life depression has 
indicated increased risk among women compared to men and among Black 
individuals compared to non-Hispanic White individuals. When investigating 
racial differences, a cross-sectional study of over 50,000 older adults30 indicated 
significantly greater odds of anhedonia (i.e., inability to feel pleasure), 
psychomotor symptoms and sadness among Black participants compared to 
non-Hispanic White participants. Results were robust even after adjustment for 
social and health determinants such as socioeconomic status, lifestyle factors 
(i.e., body mass index, physical activity, smoking and alcohol use), or 
comorbidities. Moreover, it is possible hearing loss increases vulnerability to the 
social and emotional strain and inequalities faced by many minority individuals in 
the U.S.17. This vulnerability might therefore predispose minority individuals to 
increased depressive symptoms. Further, it is possible the prolonged 




societal inequalities and racial disparities, leading to the higher relative risk or 
poorer depressive symptom trajectories observed in our analysis over time for 
Black participants. Known disparities in access to health care, utilization of health 
services, and delays to the initiation of psychosocial treatment between Black 
and White individuals exist30, which may potentially exacerbate this vulnerability. 
Further characterization of how hearing loss may have differing social and 
emotional effects by race may highlight potential avenues for intervention of 
depression.  
Prior results also suggest greater odds of depressive symptoms including 
depressed mood and somatic complaints among older women compared to older 
men (Abrams 2019). Our findings are consistent with this prior work, and 
remained consistent across measures of hearing difficulty. Prior hypotheses have 
suggested social factors may lead older women to place greater emphasis then 
older men on spoken communication to maintain connection with others5-6. 
Therefore, due to these social influences, hearing loss may have a greater 
impact on this feeling of connection in women and may result in the higher 
baseline prevalence and greater dose response over time observed in our study. 
Future investigation of the inter-relational effect of race and gender among 
hearing impaired older adults may aid in determining particular groups at the 
greatest risk of depressive symptoms as well as provide opportunity for 
personalized intervention for late-life depression. 
While the longitudinal nature of our study is a strength, we acknowledge 




elected to use the full 10 years of rich depression measures available by using 
Year 1 as baseline for our analysis. While this presents a chronological gap from 
when hearing was measured, for the majority of older adults, hearing changes 
very gradually at a rate of 1-2 dB per year35 and is an approach which has been 
used in other studies36-37. Therefore, the time between baseline and when 
audiometry was performed likely only presents a minimal change in hearing for 
most participants. We therefore do not expect significant misclassification by 
hearing category – any misclassification would likely lead to a conservative 
estimate of the association observed between hearing and depressive symptoms 
across the analyses performed. We were additionally not able to assess 
medication use for depression beyond year 6. Albeit the CES-D 10 demonstrates 
good sensitivity in identifying those with significant depressive symptoms, it is not 
a diagnostic measure for depression. It is possible this assessment may 
incorrectly capture constructs of depression which are more appropriate for older 
adults and result in misclassification of depressive symptoms. Additionally, it is 
possible we may underestimate depressive symptomatology among older adults 
or subgroups from participants’ hesitation to report depressive symptoms or seek 
treatment due to stigma associated with depression. However, a strength of our 
analysis is the multiple modes by which we are able to assess depressive 
symptoms in our study population which may better capture the presence of 
symptomatology. Cross-sectional measures of depression may be subject to 
episodic depressive symptoms related to situational circumstances such as 




therefore may not correctly reflect longer term levels of depression. Our study 
includes both cross-sectional measures, for comparability to previous studies, as 
well as two different means to assess longitudinal depression over time. This 
comprehensive assessment may more accurately reflect depressive 
symptomatology in older adults through utilization of depression questionnaires, 
self-report history for treatment or diagnosis, and use of medications prescribed 
for depression.   
Our results investigating reduced risk of depression among hearing aid 
users yielded findings which were not statistically significant. However, our 
measure of hearing aid use included self-report hearing status. Individuals 
commonly over-estimate their use of a hearing aid38 and may therefore lead to 
misclassification of hearing aid use in our participants and contribute to our null 
findings. The potential benefit of hearing aid use for management of hearing loss 
and reducing depression risk is substantial. Therefore, future study with more 
sophisticated evaluation of hearing aid use and appropriate device fitting could 
have far reaching clinical and public health benefit.  
In a longitudinal cohort study of older adults, results support an 
association between greater degree of hearing loss and both prevalent and 
incident clinically significant depressive symptoms, particularly for those with a 
moderate or greater hearing loss. We observed suggestion of an association 
between hearing loss and a borderline high clinically significant depressive 
symptom trajectory over 10 years of follow-up. Higher associations were 




providers working with older adults might consider the patient’s hearing status 
when addressing risk factors for late-life depression, as well as disparities in 
psychosocial care by race and gender. As hearing loss is modifiable with the use 
of hearing intervention strategies, understanding how hearing loss may increase 
risk for depressive symptoms, especially in subgroups of older adults, and if 
hearing aids have the potential to be considered an intervention option for late-
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Table 3.1 Baseline Demographics of the Analytic Sample and by Hearing 











 Mild hearing 
loss (N=793) 





 N (%) N (%) N (%) N (%)  
Baseline Age, mean (SD) 74.0 (2.8) 73.3 (2.7) 74.2 (2.8) 74.8 (2.9) <0.001 
PTA, mean (SD) 30.3 (13.5) 18.2 (5.1) 32.6 (4.3) 50.4 (9.1) <0.001 
Black 793 (38.0) 406 (47.2) 275 (34.7) 112 (25.7) <0.001 
Women 1082 (51.8) 531 (61.7) 398 (50.2) 153 (35.2) <0.001 
Education 
    
0.033 
   Postsecondary 933 (44.7) 391 (45.4) 364 (45.9) 178 (40.9) 
 
   High School grad 693 (33.2) 288 (33.4) 269 (33.9) 136 (31.3) 
 
   Less than High School 463 (22.2) 182 (21.1) 160 (20.2) 121 (27.8) 
 
Memphis study center 1023 (49.0) 392 (45.5) 395 (49.8) 236 (54.3) 0.010 
Marital Status 
    
0.012 
   Never Married 102 (4.9) 41 (4.8) 40 (5.0) 21 (4.8) 
 
   Married 1219 (58.4) 466 (54.1) 479 (60.4) 274 (63.0) 
 
   Widowed, Divorced, 
Separated 
768 (36.8) 354 (41.1) 274 (34.6) 140 (32.2) 
 
Live Alone 603 (28.9) 268 (31.1) 218 (27.5) 117 (26.9) 0.16 
Baseline Diabetes 727 (34.8) 279 (32.4) 282 (35.6) 166 (38.2) 0.10 
BMI, mean (SD) 27.4 (4.7) 27.4 (4.9) 27.4 (4.8) 27.1 (4.1) 0.48 
Smoking History 
    
<0.001 
   Never smoker 950 (45.5) 434 (50.4) 355 (44.8) 161 (37.0) 
 
   Former smoker 969 (46.4) 353 (41.0) 384 (48.4) 232 (53.3) 
 
   Current smoker 170 (8.1) 74 (8.6) 54 (6.8) 42 (9.7) 
 
Baseline history of CVD 1379 (66.0) 575 (66.8) 523 (66.0) 281 (64.6) 0.73 
Baseline history of depression 182 (8.7) 69 (8.0) 68 (8.6) 45 (10.3) 0.37 
CES-D 10 score, mean (SD) 2.9 (3.3) 2.8 (3.1) 2.8 (3.4) 3.0 (3.4) 0.52 
*Baseline characteristics were compared using Wilcoxon rank-sum tests and Fisher’s exact tests 
Notes: PTA= pure tone average; SD= standard deviation; BMI= body mass index; CVD= cardiovascular disease; CES-D 
10= Center for Epidemiologic Studies Depression scale short form; Mild hearing loss= PTA 25-40 dB HL; moderate or 






Table 3.2 Cross-sectional prevalence of clinically significant depressive 
symptoms or treatment for depression at baseline (1997-1998) by hearing 
category, race, and sex in HABC (N=2,089) 
 
 Normal hearing 
 
Mild Hearing Loss Moderate or greater 
Hearing Loss 
P for trend* 
 Odds Ratio [95% 
CI] 
Odds Ratio [95% 
CI] 





1.0 (Reference) 1.38 [0.78,2.43] 2.45 [1.33,4.51] 0.004 
Women 
(N=1,082) 
1.0 (Reference) 1.70 [0.83,3.47] 2.89 [1.30,6.43] 0.009 
Men 
(N=1,007) 
1.0 (Reference) 0.92 [0.35,2.44] 1.81 [0.69,4.72] 0.190 
Black 
(N=793) 
1.0 (Reference) 2.24 [0.93,5.42] 3.35 [1.25,9.01] 0.013 
White 
(N=1,296) 






Models adjusted for demographic (age, gender, race, education) and health factors (study site, marital 
status, living alone, diabetes, Body mass index, cardiovascular disease history) 
Notes: Normal hearing defined as PTA<25 dB HL, Mild hearing loss PTA >25 dB HL and ≤ 40 dB HL; 







Table 3.3 Incidence of new clinically significant depressive symptoms or 
incident treatment for depression over 10 years (1997/1998 to 2007/2008) by 





 Normal hearing 
 
Mild Hearing Loss Moderate or greater 
Hearing Loss 
P for trend* 
 HR (95% CI) HR (95% CI) HR (95% CI)  
Overall (1,978)a 1.0 (Reference) 1.15 [0.96,1.39] 1.26 [1.00,1.58] 0.037 
Women (1,014)b 1.0 (Reference) 1.15 [0.91,1.46] 1.33 [0.97,1.83] 0.062 
Men (964)b 1.0 (Reference) 1.16 [0.86,1.55] 1.20 [0.86,1.66] 0.273 
Black (744)b 1.0 (Reference) 1.11 [0.85,1.45] 1.22 [0.86,1.74] 0.239 
White (1,234)b 1.0 (Reference) 1.20 [0.90,1.48] 1.26 [0.94,1.68] 0.066 
aOverall model fully adjusted for demographics (age, gender, race, education) and health factors (study site, marital status, 
living alone, diabetes, Body mass index, cardiovascular disease history) 
b stratified models adjusted for demographics (age, gender/race, education) and excluding those reporting antidepressant use 
but not treatment for depression 
Notes: Normal hearing defined as PTA<25 dB HL, Mild hearing loss PTA >25 dB HL and ≤ 40 dB HL; Moderate or greater 














Figure 3.1 Mean CES-D 10 score per Depressive Symptom Trajectory 
across 10 years of follow-up (1997/1998 to 2007/2008) in HABC Study 
Notes: Depressive symptom trajectory created using Center for Epidemiologic Study Depression scale short-form 
(CES-D 10) responses from visits 1, 3, 5, 6, and 8 
27.1% of participants were in the moderate increasing trajectory; 66.6% in the low depressive symptom trajectory; 




Table 3.4 Relative risk ratio of depressive symptom trajectory over 10 years 







 Overall Women Men Black White 
Borderline high 
trajectory (N=132) 
     
 Mild hearing loss 1.06 1.10 1.03 1.24 0.95 
 [0.95,1.18] [0.95,1.26] [0.86,1.23] [1.04,1.48] [0.82,1.09] 
      
 ≥Moderate hearing loss 1.16 1.25 1.09 1.58 1.05 
 [1.01,1.32] [1.03,1.52] [0.89,1.32] [1.24,2.03] [0.89,1.24] 
Moderate Increasing 
trajectory (N=566) 
     
 Mild hearing loss 0.91 0.93 0.89 1.07 0.83 
 [0.84,0.98] [0.84,1.03] [0.80,1.00] [0.94,1.21] [0.75,0.91] 
      
 ≥Moderate hearing loss 0.96 1.01 0.94 1.43 0.83 
 [0.87,1.05] [0.86,1.17] [0.83,1.07] [1.19,1.73] [0.74,0.93] 
Low trajectory 
(N=1,390) 
     
 Mild hearing loss Reference Reference Reference Reference Reference 
 - - - - - 
      
 ≥Moderate hearing loss Reference Reference Reference Reference Reference 
 - - - - - 
Notes: Depressive symptom trajectory created using Center for Epidemiologic Study Depression scale short-form (CES-D 10) 
responses from visits 1, 3, 5, 6, and 8 
Models adjusted for demographics (age, gender, race, education) and health factors (study site, marital status, living alone, diabetes, 
Body mass index, cardiovascular disease history, antidepressant medication use) 
27.1% of participants were in the moderate increasing trajectory; 66.6% in the low depressive symptom trajectory; 6.3% in the 
borderline high depressive symptom trajectory 
Normal hearing defined as PTA<25 dB HL, Mild hearing loss PTA >25 dB HL and ≤ 40 dB HL; Moderate or greater hearing loss as 











CHAPTER 4: Examining the Combined Estimated Effects of 
Hearing Impairment and Depressive Symptoms on Risk of Cognitive 







Objective: The combination of two highly prevalent risk factors for dementia – 
hearing loss and depressive symptoms – may present unique risk of dementia for 
older adults. We aimed to test if rates of cognitive decline or incident dementia 
differ for participants with both hearing loss and depressive symptoms compared 
to what would be expected given their independent effects.  
Methods: Data were from the Health, Aging, and Body Composition Study 
(Health ABC), a longitudinal study of well-functioning community-dwelling older 
adults. Rates of 8-year cognitive change on the Modified Mini Mental State Exam 
and Digit Symbol Substitution Test were evaluated, and incident dementia was 
defined using a predetermined algorithm incorporating medication use, hospital 
records and neurocognitive tests. Depressive symptomatology was defined in 3 
ways, CES-D 10 ≥ 10: (i) Baseline: on the exam at baseline; (ii) Persistent: at 
both of the first 2 times points; or (iii) Repeated: more than one year during the 
first 4 years of follow-up (not required to be consecutive). Hearing loss was 
determined via pure-tone average (PTA) in the better hearing ear at 500-4000 Hz 
and categorized as normal or mild hearing loss (PTA<40 dB HL) vs moderate or 
greater hearing loss hearing loss (PTA ≥ 40 dB HL). Associations between 
hearing loss, depressive symptoms and rates of cognitive decline or incident 
dementia were assessed using linear mixed effects models and Cox proportional 
hazards models, respectively. 
Results: The coupling of hearing loss and depressive symptoms – regardless of 




compared to the group with no significant hearing loss or depressive symptoms. 
The hazard for incident dementia was greatest among the group with both 
moderate or greater hearing loss and either baseline depressive symptoms (HR: 
3.81, 95% CI: 1.90, 7.62) or repeated depressive symptoms (HR: 2.91, 95% CI: 
1.59, 5.33). 
Conclusion: The combined presence of both hearing loss and depressive 
symptomatology (particularly symptoms lasting for more than one year) 
presented the fastest rates of cognitive change on cognitive tests as well as 
greatest risk for incident dementia, compared to those with no significant hearing 
loss or depressive symptoms. The observed estimated effect was greater than 
the independent estimated effect of each risk factor. Subgroups of older adults 
with hearing loss who further present with depressive symptomatology may 
introduce a unique opportunity for clinical and public health intervention for 












With the growing prevalence of dementia in the United States, there is a 
pressing need to identify potential avenues for prevention of dementia and 
cognitive decline. In the U.S., an estimated 5.8 million individuals were living with 
Alzheimer’s disease in 2020, expected to increase to nearly 14 million by 20501. 
Hearing impairment is an independent and modifiable risk factor for dementia2. 
Over two-thirds of adults over the age of 70 years have a hearing loss3. 
Moreover, around 67% of older adults of Medicare age have multimorbidity4; 
therefore, hearing impairment is likely present in older adults along with other 
health conditions. Given the high prevalence of hearing impairment in older 
adults, identification of differences in dementia risk by subgroups of older adults 
with concurrent modifiable risk factors for cognitive decline could have 
meaningful public health benefit.  
Late-life depression is one such potential comorbidity that may co-occur in 
older adults with hearing loss, as the prevalence of depressive symptoms is 
estimated at around 15% in a community-sample of older adults5. Depressive 
symptomatology in older adults may present as a heterogeneous course, 
susceptible to variation over time or acute instances from life events5. 
Furthermore, depression itself has been identified as another independent 
modifiable risk factor for dementia2.    
While the independent effects of hearing impairment, clinical depression 
and increased depressive symptoms on cognitive decline and dementia in older 




conditions has received little study. A prior study of 8,529 participants aged 60 
years or older from the National Alzheimer's Coordinating Center Uniform Data 
Set, one of the few studies to consider both hearing loss and depression, 
investigated the potential mediating effect of depression and found no evidence 
of suggested change in the hearing loss-dementia association8. Although 
mediation analyses have benefit for understanding mechanisms, analyses of 
modification (i.e., interaction) have important public health relevance for the 
identification of high-risk groups. As hearing loss and depression are both 
potentially modifiable, understanding if the risk presented by each condition in 
isolation differs from the risk in the presence of both conditions may allow for 
more targeted dementia intervention efforts in older adults.  
Our study objectives, using data from the Health Aging and Body 
Composition (Health ABC) study, are to test if (i) rates of cognitive decline and (ii) 
risk of incident dementia differ for participants with both hearing loss and 
depressive symptoms compared to what would be expected given their 
independent effects. We hypothesized the additional presence of depressive 
symptomatology among hearing impaired older adults demonstrates faster rates 






4.2.1 Study Population 
Participants were enrolled in the Health ABC study, a biracial prospective 
study of 3,075 community dwelling older adults, aged 70-79 years at study 
initiation in 1997-1998 (visit 1), recruited from Pittsburgh, Pennsylvania or 
Memphis, Tennessee9.  As the Health ABC Study was designed to assess 
differences in function, disability, and longevity across race (Black vs. White) and 
gender, participants enrolled in the study were free of difficulty walking ¼ mile or 
difficulty climbing up 10 steps at baseline. This study was approved by the 
Institutional Review Boards of all participating institutions. Audiometric hearing 
was assessed at study year 5 (2001-2002).  
4.2.1.a Analytic Sample: Rates of Cognitive Decline 
From an initial sample of 3,075, a total of 2,198 participants had complete 
audiologic measures (872 excluded), and completed the baseline Center for 
Epidemiologic Study depression scale (CES-D) and self-reported depression 
medication use measured at baseline (5 excluded). We excluded 137 
participants who were missing baseline covariates or had less than 2 measures 
of the Modified Mini-Mental State Exam (3MS) or the Digit Symbol Substitution 
Test (DSST) during the 10 years of follow-up. Our final analytic sample was 
2,061.  
4.2.1.b Analytic Sample: Incident Dementia 
Of the 2,034 study participants who had complete audiologic measures in 




excluded), and had completed baseline CES-D scores (10 excluded), an 
additional 214 participants were missing covariate data leading to an analytic 
sample in our secondary analysis of 1,820 participants. 
4.2.2 Cognitive Decline 
Two neurocognitive tests, the Modified Mini-Mental State Exam (3MS)10 
and the Digit Symbol Substitution Test (DSST)11 were collected six times during 
the study: Year 1 (1997-1998), Year 3(1999-2000), Year 5 (2001-2002), Year 8 
(2004-2005), Year 10 (2006-2007) and Year 11 (2007-2008).  
As a test of global cognitive function, the 3MS10 provides an assessment 
of an individual’s orientation, registration, attention, calculation, recall and visual-
spatial skills similar to the 30-item Mini-Mental State exam (MMSE)12 it was 
adapted from.  Expanded from the 30-item MMSE and scored from 0-100, this 
modification from the 30-item scale is designed for enhanced reliability and 
validity.  
The DSST11 tests attention, processing speed, and executive function 
requiring the participant to use a key of symbols and matched numbers to 
translate the corresponding number and symbol as fast as possible. Scoring is 
completed as the total number of symbols correctly matched within 90 seconds 
time - higher scores indicate better performance. 
4.2.3 Incident Dementia 
As has been implemented in prior work13-14, incident dementia was defined 




memantine, donepezil, or tacrine), a dementia diagnosis from adjudicated 
hospital records, or a race-stratified 3MS decline of more than 1.5 standard 
deviations from the baseline mean. Medication use and hospital records were 
assessed annually. 
4.2.4 Hearing Loss  
Hearing acuity measures were performed via audiometry in a sound-proof 
booth at Year 5 (2001-2002). Air conduction thresholds, as measured in decibels 
hearing level (dB HL), were completed in each ear from 250 Hz to 8000 Hz with 
TDH 39 headphones using a MA40 audiometer (Maico Diagnostics, Eden Prairie, 
MN) calibrated to the American National Standards Institute standards (ANSI 
S3.6-1996).  
For comparison of hearing levels, we calculated a commonly used metric 
of the speech frequency pure tone average (PTA) using thresholds at 500, 1000, 
2000, and 4000 Hz in the better hearing ear in agreement with the World Health 
Organization’s definition of hearing loss15. We created a binary variable of 
hearing loss according to common clinical cutpoints (normal hearing or mild 
hearing loss, PTA<40 dB HL; moderate or greater hearing loss, ≥40 dB HL). 
Moderate or greater hearing loss is recognized as a level at which hearing 





4.2.5 Depressive Symptoms 
Depressive symptoms were assessed using the Center for Epidemiologic 
Studies Depression Scale (CES-D)17, including both the full 20-item scale (Year 
1) and abbreviated 10-item scale (Years 3-11). All scores were converted to the 
CES-D 10 scale. For our analysis, we utilized CES-D 10 scores from the start of 
follow-up until when hearing was assessed (Years 1, 3, 4, and 5) and defined 
significant depressive symptoms as a CES-D 10 score ≥1018-19. A history of 
having ever been treated for depression was ascertained at Year 1. Baseline 
depressive symptoms were therefore defined as a CES-D 10 score ≥10 at Year 1 
or the presence of medication intended for depression. In order to better 
understand how the potential variability in depressive symptom presentation over 
time might modify the hearing-dementia relationship, we modeled depressive 
symptoms incorporating repeated measures in two ways. First, we modeled 
persistent depressive symptoms, defined as elevated CES-D 10 scores (≥10) at 
both Years 1 and 3 or reported treatment for depression, with the goal of 
capturing ongoing depressive symptomology rather than acute instances that 
may be related to transient life events. Second, we modeled repeated depressive 
symptoms as any repeated instance (consecutive or not) of clinically significant 
depressive symptoms (≥1 elevated CES-D 10 score at Years 1, 3, 4 or 5) (Table 
4.1). 
4.2.6 Additional Independent Variables 
We included age (years), gender (determined from sex identified at birth; 




education (less than post-secondary vs post-secondary or greater) as measured 
at Year 1 (1997-1998). We also included a number of health related factors. 
Diabetes was considered present if prevalent at Year 1, defined as physician-
diagnosed diabetes (reported by the participant), use of diabetes drug, or a 
fasting glucose ≥126mg/dL. Hypertension was considered present if prevalent at 
baseline (systolic blood pressure ≥140 mmHg, or diastolic blood pressure >90 
mmHg, or by participant self-report of a diagnosis by a physician with or without 
antihypertensive medication use). History of stroke was assessed at baseline by 
the question, “Has a doctor ever told you that you had a stroke, mini-stroke, or 
TIA?”. Smoking status (ever vs. never) was assessed at baseline by the 
questions “Do you smoke cigarettes now” and “Have you smoked at least 100 
cigarettes in your life”. Body mass index (BMI, continuous kg/m) was evaluated 
at baseline.  Marital status (never married, married, widowed/divorced/separated) 
was evaluated with the question “What is your marital status”. Living alone 
(yes/no) was defined as reported presence of living with one or more individuals 
vs none. As it is possible hearing aid use for the management of hearing loss 
may influence the estimated risk presented by hearing loss alone or in the 
presence of other conditions, in a sensitivity analysis, we will additionally adjust 
for self-reported hearing aid use at baseline. All time-varying covariates were 





4.2.7 Statistical Analysis 
Descriptive analysis compared demographic information and clinical 
characteristics across level of hearing status. Baseline characteristics were 
compared using means and standard deviations and ANOVA tests for continuous 
measures. Categorical variables were described using frequencies with 
differences tested using chi-square tests.  
We used linear mixed effects models with person-specific slopes and 
intercepts to assess differences in rates of cognitive decline by hearing and 
depressive symptom status. Cognitive decline on the DSST and 3MS was 
modeled separately. The linear mixed model accounts for the correlation 
between repeated measures over time within an individual20. We assumed an 
unstructured correlation matrix. We used Cox proportional hazard models to 
investigate risk of incident dementia by depressive symptom status and category 
of hearing acuity over 9 years of follow-up. We confirmed the proportionality 
assumption via Schoenfields residuals21 and included an interaction between our 
exposure and time. For assessment of incident dementia, time on study was 
used as the time scale, with Year 3 (1999-2000) as the time origin. As most 
participants were not at risk for incident dementia until the second administration 
of the 3MS at Year 3, our time origin was modeled as Year 3 (1999-2000). For 
our analysis, follow-up for incident dementia continued until Year 11 (2007-2008) 
at the last time the 3MS was administered to our study sample 
We described differences in the association of hearing and cognition by 




observational studies22-23: (1) modelling the joint risk of dementia using 4 
exposure categories – (i) normal hearing or mild hearing loss and no depressive 
symptoms (reference group), (ii) depressive symptoms only, (iii) hearing 
impairment only, and (iv) both hearing impairment and depressive symptoms and 
(2) inclusion of an interaction term between hearing impairment and depressive 
symptoms in the regression model. In our analysis of incident dementia, we also 
stratified results of the hazard of incident dementia from hearing loss by 
depressive symptoms status, as well as the hazard from depressive symptoms 
by hearing status. This framework enabled us to assess the presence of both 
joint effects (i.e., 4 exposure categories) and heterogeneity of effects (i.e., 
interaction term) of depressive symptoms and hearing loss on cognitive 
outcomes.  
Model fit for both analyses was assessed using residual plots and through 
statistical methods including the Bayesian Information Criterion (BIC), Akaike 
Information Criterion (AIC), and likelihood ratio tests. As the additive scale has 
important public health implications24, for our analysis of incident dementia we 
present the independent and combined estimated effect of exposures on the 
additive scale using the relative excess risk of interaction (RERI) and the synergy 
index (ratio between the combined effect of an exposure and the individual 
effects)25-26 and include a 95% confidence interval calculated via the delta 
method22, 27. 
We adjusted for gender, education (post-secondary vs less than post-




absence of hypertension or diabetes, body mass index (BMI), marital status 
(never married, married, widowed/divorced/separated), and living alone. All 
analysis were completed using STATA 15.0 (StataCorp. 2017).  
4.2.7.a Sensitivity Analysis 
In a sensitivity analysis, we additionally adjusted for self-reported hearing 
aid use at baseline to understand if management of hearing loss may alter the 
effect estimates observed. Additionally, we repeated our analysis evaluating the 
combined estimated effects of hearing loss and depressive symptoms on 
cognitive decline and incident dementia using Year 5 as the study baseline, as 
that is when hearing was measured.  
  
4.3 RESULTS 
4.3.1 Descriptive Analysis 
In our analytic sample of 2,061 participants, 20.7% had a moderate or 
greater hearing loss, and 7.1% had clinically significant depressive symptoms at 
baseline. Sixty-one participants (3.0%) experienced persistent depressive 
symptoms at both Years 1 and 3, while 220 (10.7%) had repeated depressive 
symptoms over the first 4 years of follow-up.  Categorizing participants based 
both on hearing status and baseline depressive symptoms, 1,529 (74.2%) had 
normal hearing or mild hearing loss and no baseline depressive symptoms, 385 
(18.7%) had a moderate or greater hearing loss only, 104 (5.0%) had clinically 




significant hearing loss and depressive symptoms. Those without significant 
hearing loss or depressive symptoms were generally younger and female 
compared to those with hearing loss and/or depressive symptoms (Table 4.2). 
4.3.2 Baseline Cognitive Test Performance and Rates of Cognitive Decline 
Compared to participants with neither significant hearing loss nor baseline 
depressive symptoms, participants with a moderate or greater hearing loss 
(without depressive symptoms) on average had lower baseline test scores (-0.86; 
95% CI: -1.53, -0.18 on 3MS; -0.81; 95% CI: -2.08, 0.47 on DSST), and faster 
rates of decline on both the 3MS (-0.14; 95% CI: -0.26, -0.02) and DSST (-0.17; 
95% CI: -0.29, -0.05). Results were consistent across all ways of measuring 
depressive symptoms (Table 4.3).   
The association between depressive symptoms alone, without hearing 
impairment, varied by how depressive symptoms were measured. We found no 
evidence of an association between baseline depressive symptoms and baseline 
test performance or rates of cognitive decline. Persistent depressive symptoms 
(depressive symptoms reported at Year 1 and Year 3) was associated with lower 
baseline DSST scores (-3.25; 95% CI: -6.20, -0.30) but not with baseline 3MS 
scores, nor with rates of decline in either test. However, depressive symptoms at 
repeated visits (depressive symptoms at more than one time point between Year 
1 and Year 5) was consistently associated with poorer baseline scores (-1.34; 
95% CI: -2.30, -0.38 on 3MS; -1.94; 95% CI: -3.77, -0.11 on DSST) and faster 
rates of cognitive decline for both tests (-0.21; 95% CI: -0.37, -0.05 on 3MS; -




When considering the estimated joint effect for both hearing loss and 
depressive symptoms, moderate or greater hearing loss and persistent 
depressive symptoms, compared to no hearing loss or mild loss and no 
depressive symptoms, was associated with lower average baseline test scores 
on the 3MS (-1.91; 95% CI: -3.74, -0.09). We found no associations for hearing 
loss plus other measures of depressive symptoms (baseline, repeated) on 
baseline 3MS scores, or on the DSST at baseline. However, faster rates of 
cognitive decline were observed across all measures and tests, significantly 
faster with repeated depressive symptoms on the DSST (-0.64; 95% CI: -1.27, -
0.01) and on both tests for persistent depressive symptoms (-0.30; 95% CI: -
0.78, -0.19 3MS; -0.35; 95% CI: -0.67, -0.03). 
4.3.3 Incident Dementia 
Over 9 years, 223 (12.2%) participants developed incident dementia. 
Relative to those without significant hearing loss (normal hearing or mild hearing 
loss) or clinically meaningful depressive symptoms, those with moderate or 
greater hearing loss demonstrated a significantly greater risk of incident 
dementia across all ways of measuring depressive symptoms (HR: 1.42, 95% CI: 
1.03, 1.95 baseline symptoms and 1.54, 95% CI: 1.10, 2.15 repeated symptoms) 
(Table 4.4). 
The association in those with clinically significant depressive 
symptomatology alone without hearing impairment is suggestive of greater risk 




greater risk for incident dementia with repeated depressive symptoms over the 
first 4 years of follow-up (HR: 2.35, 95% CI: 1.56, 3.53) (Figure 2).  
The strongest estimated risk for incident dementia was observed for the 
presence of both hearing loss and depressive symptoms across both measures 
of depressive symptoms used (HR: 3.81; 95% CI: 1.90, 7.62 baseline; HR: 2.91; 
95% CI: 1.59, 5.33 repeated). 
To present results on an additive scale, the relative excess of interaction 
(RERI) for baseline depressive symptoms is suggestive of an interaction (RERI: 
1.69. 95% CI: -1.10, 4.47), though not significant. A measure of the excess risk 
from exposure to both exposures relative to the risk from no exposure 
interaction27 (Synergy Index) again suggests a departure from additivity (S: 2.51; 
95% CI: -0.87, 5.88) for baseline depressive symptoms. Our investigation of the 
heterogeneity of the effects of each exposure on incident dementia, while not 
statistically significant, suggests heterogeneity in the degree of risk, with greater 
risk presented by the presence of both comorbid conditions (Figure 4.2). 
4.3.4 Sensitivity Analysis 
In a sensitivity analysis using when hearing was measured as baseline 
Year 5), the estimated effects were overall similar for rates of cognitive decline as 
well as incident dementia and inferences were unchanged. In models adjusted 
for self-reported hearing aid use, results for each analysis were again similar in 






In a longitudinal investigation of 2,061 older adults over 11 years of follow-
up from the Health ABC Study, moderate or greater hearing loss (vs. normal or 
mild loss) was associated with faster rates of cognitive decline and greater risk of 
incident dementia independent of depressive symptom status in all analyses. The 
presence of clinically significant depressive symptoms alone was associated with 
faster rates of cognitive change and incident dementia, particularly when 
symptomatology was repeated at more than one year of follow-up. While each 
independent condition demonstrates elevated risk for cognitive impairment, 
individuals with hearing loss who additionally developed depressive symptoms 
overall presented the greatest estimated risk for both rates of cognitive decline 
and risk of incident dementia – highlighting potential dementia prevention 
opportunities. Findings suggest the presence of depressive symptoms among 
hearing impaired older adults may play a modifying role in the hearing-dementia 
relationship. Intervention on hearing loss and depressive symptoms may have 
the potential to improve quality of life for a significant number of older adults in 
our population and clinics. 
While many other studies have looked at the hearing-dementia or 
depression-dementia link in isolation, few have considered the risk presented by 
the joint presence of these two independent risk factors for dementia. Our results 
uniquely consider both the independent estimated effects of hearing and 
depressive symptoms as well as the combined presence of depressive 




length of depressive symptoms exists, our study investigated differences in risk 
by longevity of depressive symptom status. Findings suggest those with clinically 
significant hearing loss at a level which may impair communication ability are at 
risk for a significantly faster rate of cognitive change as well as increased risk of 
incident dementia, especially among those who additionally develop clinically 
meaningful depressive symptomatology. Additional study of potential biological 
interaction or a biological vs behavioral/social mechanism behind this relationship 
may further inform our dementia intervention efforts.  
The findings presented compliment prior research completed within the 
National Alzheimer’s Coordinating Center data set which performed a mediation 
analysis of hearing loss, late-life depression, and dementia8. While this study did 
not find that depression mediated the hearing-dementia relationship, results 
indicated treated hearing loss (defined as participants who wore hearing aids 
resulting in perceived functionally normal hearing) was associated both with 
depression and conversion to dementia. In contrast, our analysis quantified how 
the combined presence of clinically meaningful depressive symptoms among 
those with significant hearing loss presents differing risk for cognitive change or 
dementia than the presence of each condition in isolation, highlighting a potential 
interrelated link between hearing loss, depression, and dementia which has 
notable clinical relevance.  
A strength of our study was the investigation of the estimated effect 
among hearing impaired adults with the additional presence of depressive 




to measure depressive symptoms, the estimated effect on rates of cognitive 
decline was more consistent with DSST measures than with 3MS measures. 
However, our test scores were not standardized, therefore we exercise caution in 
comparison of rates of change across cognitive tests. It is possible the observed 
estimated combined effect failed to reach significance in our analysis due to our 
overall small sample size (i.e., 17 participants with both persistent depressive 
symptoms and hearing loss, 43 with baseline depressive symptoms and hearing 
loss). These small sample sizes may have limited power and the width of 
confidence intervals obtained, therefore placing constraints on available 
inferences.  
Although our small sample size limits the inferences possible from our 
analysis of the combined estimated effects of hearing and depressive symptoms 
on cognition, the greater estimated observed effect among those with both 
conditions presents public health and clinical opportunity. As the ability to hear 
and communicate effectively has a significant influence on life and behaviors, it is 
possible the additional development of depressive symptomatology – particularly 
that lasting longer than an acute event – among those with hearing loss 
exacerbates psychosocial or neuropsychological buffers and may lead to 
accelerated cognitive decline. With this in mind, consideration of low-risk 
strategies which could minimize the adverse effects of each condition, such as 
the use of hearing aids to manage hearing loss and cognitive behavioral therapy 
for depressive symptoms, could have downstream beneficial impacts for older 




depression may be less likely to seek or adhere to clinical or public health 
recommendations28-30. However, the use of hearing aids or other forms of 
management for hearing loss has the potential to alter this risk landscape. In our 
analytic sample, we observed those with repeated depressive symptoms who 
developed incident dementia had nearly 10% lower prevalence (27% vs 16%) of 
self-reported hearing aid use compared to those who remained free of dementia 
at the end of follow-up. When restricting to those with a moderate or greater 
hearing loss only, those with depressive symptoms who reported hearing aid use 
showed a suggestion of, but not statistically significant, qualitatively protective 
effect of incident dementia and cognitive decline, although small sample size 
limited inference. 
Our study was limited in the ascertainment of the presentation of 
depressive symptoms via one evaluative scale, the CES-D 10. While the CES-D 
is not a comprehensive medical evaluation and is subject to episodic depression 
or may miss certain aspects of late-life depression in older adults, the CES-D has 
widespread use and has demonstrated good reliability and validity of 
symptoms18-19. The number of repeat measures of CES-D 10 over time is a 
strength of our study. Additionally, hearing was not measured until Year 5 of the 
study. However, hearing generally changes very gradually at 1-2 dB per year in 
adults31-32. We therefore would expect minimal misclassification of hearing status 
for our analysis. We opted to consider Year 1 as our study baseline to capitalize 
on a longer follow-up period and richer data, particularly for depression treatment 




baseline, while reduced in magnitude, also suggested the greatest risk for 
cognitive change and incident dementia was among those with both conditions.  
Our results highlight how consideration of comorbid conditions, each 
independent risk factors for dementia, could potentially present pivotal 
intervention options and have far-reaching benefits for older adults. Management 
and consideration of hearing loss in conjunction with other conditions may have 
beneficial effects beyond just communication ability. With the high prevalence of 
hearing loss among older adults and under-utilization of treatment strategies 
such as hearing aids, significant room for intervention and potential interruption 
of the hearing-depression-dementia relationship exists. While we completed 
sensitivity analyses with models adjusted for reported hearing aid use at 
baseline, our measure of hearing aid use was via self-report, leaving potential 
room for misclassification as many adults over-report on their hearing aid use33. 
Continued investigation of how the management of hearing loss may influence 
downstream psychosocial outcomes using a more specific and valid assessment 
of hearing aid use may greatly improve our understanding of how intervention on 
these measures may reduce dementia risk. Current clinical trials of hearing aid 
use among older adults are underway and may further aid in our understanding 
and quantification of the broad benefits of hearing management.  
In a longitudinal cohort study of 2,061 older adults, the combined 
presence of moderate or greater hearing loss and depressive symptoms 
demonstrated the highest estimated effect on the rates of cognitive decline and 




symptoms were each associated with greater risk for incident dementia. While 
our results warrant further investigation, clinical providers of older adults, 
particularly those with hearing loss, may consider co-existing psychosocial 
conditions such as depression. Identification of low-risk intervention options for 
dementia among subgroups of older adults at a particularly greater risk for 
cognitive decline or dementia could vastly improve public health strategies as 
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Table 4.1 Cross-sectional and Longitudinal Measures of Depressive 
Symptoms utilized 
Measure Definition 
Baseline CES-D 10 score ≥ 10 at Year 1(1997-1998) 
 
Reported treatment for depression 
Persistent CES-D 10 score ≥ 10 at the first two administrations of the CES-D at Year 
1(1997-1998) and Year 3(1999-2000)  
 
Reported treatment for depression 
Repeated CES-D 10 score ≥ 10 at more than one administrations of the CES-D 
between Year 1(1997-1998) and Year 5(2001-2002)  
 
Reported treatment for depression 
  
Notes: CES-D 10: Center for Epidemiologic Depression Scale short form; reported treatment for 















Normal or mild 









Hearing Loss & 
Depressive 
Symptoms  
Characteristic Overall N (%) N (%) N (%) N (%) p-value 
N 2061 1529 385 104 43  
Baseline age, mean (SD) 74.0 (2.8) 73.7 (2.8) 74.9 (2.9) 73.8 (2.8) 74.7 (2.8) <0.001 
PTA, mean (SD) 30.3 (13.5) 25.0 (8.6) 50.7 (9.1) 26.7 (7.7) 47.5 (8.5) <0.001 
BMI, kg/m2, mean (SD) 27.4 (4.7) 27.4 (4.8) 27.1 (4.1) 27.8 (4.4) 26.9 (4.2) 0.52 
Black 776 (37.7) 630 (41.2) 95 (24.7) 39 (37.5) 12 (27.9) <0.001 
Women 1072 (52.0) 849 (55.5) 131 (34.0) 74 (71.2) 18 (41.9) <0.001 
Post-secondary education 1136 (55.1) 828 (54.2) 218 (56.6) 59 (56.7) 31 (72.1) 0.11 
Memphis 1009 (49.0) 731 (47.8) 214 (55.6) 46 (44.2) 18 (41.9) 0.025 
Marital status      0.11 
   Never Married 103 (5.0) 79 (5.2) 18 (4.7) 3 (2.9) 3 (7.0)  
   Married 1201 (58.3) 882 (57.7) 242 (62.9) 51 (49.0) 26 (60.5)  
  Widowed/Divorced/Separated 757 (36.7) 568 (37.1) 125 (32.5) 50 (48.1) 14 (32.6)  
Live alone  594 (28.8) 437 (28.6) 104 (27.0) 40 (38.5) 13 (30.2) 0.14 
Diabetes 714 (34.6) 531 (34.7) 144 (37.4) 22 (21.2) 17 (39.5) 0.018 
Smoking 1119 (54.3) 799 (52.3) 238 (61.8) 51 (49.0) 31 (72.1) <0.001 
Hypertension 1018 (49.4) 763 (49.9) 173 (44.9) 60 (57.7) 22 (51.2) 0.11 
Stroke 158 (7.7) 121 (7.9) 25 (6.5) 9 (8.7) 3 (7.0) 0.79 
Persistent Depressive symptoms 61 (3.0) 0 (0.0) 0 (0.0) 44 (42.3) 17 (39.5) <0.001 
Baseline CES-D 10, median 
(IQR) 2.0 (0.0, 4.0) 2.0 (0.0, 4.0) 2.0 (0.0, 4.0) 10.0 (10.0, 13.0) 11.0 (2.0, 12.0) <0.001 
Repeated Depressive symptoms 220 (10.5) 0 (0.0) 0 (0.0) 167 (8.1) 53 (2.6)  
DSST, mean (SD) 37.5 (14.1) 37.9 (14.1) 36.3 (13.7) 37.8 (15.7) 32.3 (14.7) 0.018 
3MS, median (IQR) 93.0 (88.0, 96.0) 93.0 (88.0, 97.0) 92.0 (87.0, 96.0) 94.0 (88.0, 97.0) 93.0 (84.0, 96.0) 0.013 
Note: Health ABC= Health, Aging, and Body Composition study; PTA= pure tone average; BMI= body mass index; CES-D 10= Center for 
Epidemiologic Study Depression Scale short form; persistent depressive symptoms= CES-D 10 score ≥10 on the first two evaluations; repeated 
depressive symptoms= more than one CES-D 10 score ≥10 during the first 4 years of follow-up; DSST= Digit Symbol Substitution Test; 3MS= 




Table 4.3 Independent and Joint effects of Hearing and Depressive 
Symptom Status on Difference in Baseline Cognitive Test Score and Rate 
of Cognitive over Decline per Year across Measures of Depressive 
Symptoms over 11 years of follow-up (N=2,061) 
 
 
   Modified Mini-Mental State Exam 
Digit Symbol Substitution Exam 




change per Year 
(95% CI) 
Difference in  
Baseline score 
Difference in 
change per Year 
(95% CI) 
Normal Hearing or 
Mild Hearing Loss 
No Baseline 
Depressive Symptoms 
1,529 Reference Reference Reference Reference 
 Baseline Depressive 
Symptoms 





385 -0.86 (-1.53, -0.18) -0.14 (-0.26, -0.02) -0.81 (-2.08, 0.47) -0.17 (-0.29, -0.05) 
 Baseline Depressive 
Symptoms 
43 -0.78 (-2.35, 0.78) -0.35 (-0.74, 0.04) -2.44 (-5.21, 0.34) -0.16 (-0.46, 0.15) 
Interaction (p 
value) 
  0.91 0.31 0.15 0.54 
Normal Hearing or 
Mild Hearing Loss 
No Persistent 
Depressive Symptoms 
1,589 Reference Reference Reference Reference 
 Persistent Depressive 
Symptoms 





411 -0.82 (-1.50, -0.15) -0.16 (-0.28, -0.04) -1.20 (-2.45, 0.06) -0.15 (-0.26, -0.04) 
 Persistent Depressive 
Symptoms 
17 -1.46 (-4.44, 1.52) -0.48 (-1.31, 0.35) 0.26 (-3.47, 3.99) -0.64 (-1.27, -0.01) 
Interaction (p 
value) 
  0.61 0.44 0.05 0.18 
Normal Hearing or 
Mild Hearing Loss 
No Repeated 
Depressive Symptoms 
1,322 Reference Reference Reference Reference 
 Repeated Depressive 
Symptoms 





343 -0.87 (-1.57, -0.16) -0.18 (-0.30, -0.07) -1.39 (-2.70, -0.08) -0.16 (-0.28, -0.05) 
 Repeated Depressive 
Symptoms 
85 -1.91 (-3.74, -0.09) -0.30 (-0.78, -0.19) -0.26 (-3.29, 2.77) -0.35 (-0.67, -0.03) 
Interaction (p 
value) 
  0.79 0.72 0.09 0.89 
Note: Depressive symptom= CES-D 10 score ≥ 10 at baseline of visit 1; Persistent depressive symptoms= CES-D 10 score ≥ 10 during the first two 
measures of the CES-D (visit 1 and visit3); Repeated Depressive Symptoms= CES-D 10 score ≥ 10 on more than one evaluation of CES-D during first 4 





Figure 4.1 Estimated Mean Scores on Cognitive Test by Exposure and 
Measure of Depressive Symptom in the Health ABC Study over 11 years of 
follow-up (N=2,061) 
  
FIGURE 4.1 A. Estimated mean 3MS score over follow-up by hearing loss and baseline depressive symptoms status, B. Estimated mean 
3MS score over follow-up by hearing loss and persistent depressive symptoms status, C. Estimated mean 3MS score over follow-up by 
hearing loss and repeated depressive symptoms status, D. Estimated mean DSST score over follow-up by hearing loss and baseline 
depressive symptoms status, E. Estimated mean DSST score over follow-up by hearing loss and persistent depressive symptoms status, F. 
Estimated mean DSST score over follow-up by hearing loss and repeated depressive symptoms status. 
Notes: BL Depressive symptoms= CES-D 10 score ≥ 10 at baseline of visit 1; Pers Depressive symptoms= repeated depressive symptoms, 
CES-D 10 ≥ 10 at visit 1 & visit 3;  Rep Depressive Symptoms= repeated depressive symptoms, CES-D 10 ≥ 10 at more than one visit 
between visits 1-5; HL= moderate or greater hearing loss; Referent= normal or mild hearing loss and no depressive symptoms (CES-D 10 






Table 4.4 Multivariable-adjusted Hazard Ratios (HR) and 95%  Confidence 
Intervals (CI) of the Joint Association between Hearing Impairment and 
















 No Depressive Symptoms  
Depressive  Symptoms  








 HR (95% CI) 
Normal or Mild  145/1,233  1.00 [Ref]  11/57  1.70 (0.92, 3.15) 
≥ Moderate  58/293  1.42 (1.03, 1.95)  9/14  3.81 (1.90, 7.62) 
 No Depressive Symptoms  
Repeated Depressive Symptoms 
 








 HR (95% CI) 
Normal or Mild  127/1,184  1.00 [Ref]  29/106  2.35 (1.56, 3.53) 
≥ Moderate  55/275  1.54 (1.10, 2.15)  13/32  2.91 (1.59, 5.33) 
RERI (95% CI) = 1.69; 95% CI (-1.10, 4.47) depressive symptoms; 0.02; 95% CI (-1.93, 1.97) repeated depressive symptoms 
Synergy Index (95% CI) = 2.51; 95% CI (-0.87, 5.88) depressive symptoms; 1.01; 95% CI (-0.03, 2.04) repeated depressive 
symptoms 
* Adjusted for age, gender, race, education, study center, marital status, living alone, BMI, hypertension, stroke history, and 
diabetes 
Note: HR= hazard ratio; Depressive symptoms= CES-D 10 score ≥ 10 at baseline of visit 1; Repeated Depressive Symptoms= 





Figure 4.2 Stratified hazard ratio of incident dementia for heterogeneity of effect 






FIGURE 4.2 Left panel: hazard ratio of incident dementia among strata of hearing loss; Right panel: hazard of 
incident dementia among strata of depressive symptoms.  
Note: Depressive symptoms= CES-D 10 score ≥ 10 at baseline of visit 1; Repeated Depressive Symptoms= CES-D; 


















5.1 Summary of findings 
The overall goal of this thesis was to continue our elucidation of how 
hearing loss may fit into a broader framework for dementia and late-life mental 
health. This meant first understanding what we currently know regarding the 
association between hearing loss and dementia, and identifying areas for 
research that, in our view, allow for the most substantial clinical and public health 
advances. In doing so, we aimed to build an understanding of how hearing loss 
may influence additional risk factors for dementia and how/if the combination of 
hearing loss with these other risk factors further influences dementia risk.  
5.1.2 Chapter 2: Hearing and Cognition  
While there are decades of research revolving around the contribution of 
age-related hearing loss to dementia risk, growing evidence of the adverse 
consequences of hearing loss for older adults has brought conversations about 
hearing health and care into the clinical exam room and to the attention of older 
adults and policy makers. The human and economic expense of caring for the 
coming wave of adults reaching or past retirement age demands interdisciplinary 
collaboration. Auditory science and hearing researchers have the opportunity to 
contribute to efforts to reduce this impact. Identification of mechanism(s) driving 
the association between hearing and dementia, directed hearing-dementia 
research for the greatest public health impact and societal needs, and thoughtful 
translation of this research for clinicians and patients can have a monumental 




interdependent and synergistic processes of hearing and cognition require 
careful approach. Optimizing our strategies to treat hearing loss could diminish 
the risk of adverse outcomes and enhance health and quality of life for older 
adults 
5.1.3 Chapter 3: Hearing loss and Risk of Depressive Symptoms in Older 
Adults in the Health ABC Study 
In a demographically diverse population-based cohort of 2,089 older 
adults in the United States with up to 10 years of follow-up, we investigated the 
impact of hearing loss on depressive symptoms using a comprehensive definition 
of depression which incorporates self-reported history of depression, medication 
use, and questionnaires. Those with hearing loss demonstrated significantly 
greater odds of clinically significant depressive symptoms at baseline and 
suggested greater risk for incident clinically significant depressive symptoms over 
follow-up. Results were robust even after covariate adjustment and consideration 
of a history of treatment for depression. Analysis of depressive symptoms over 
time suggest greater risk for a poorer depressive symptom trajectory for those 
with hearing loss, particularly moderate or greater loss, compared to those with 





5.1.4. Chapter 4: Examining the Combined Estimated Effects of Hearing 
Impairment and Depression on Risk of Cognitive Decline and Incident 
Dementia in the Health ABC study 
In a longitudinal cohort study of 2,061 older adults, the combined 
presence of moderate or greater hearing loss and depressive symptoms 
demonstrated a greater association with risk of incident dementia than would be 
expected from the independent contributions of each risk factor. The rate of 
cognitive decline on the Digit Symbol Substitution test was steeper among those 
with both moderate or greater hearing loss and repeated or persistent depressive 
symptoms. While the rate of change was not significant for the Modified Mini-
Mental State Exam, the fastest rate of change was observed for those with both 
risk factors. While our results warrant further investigation, clinical providers of 
older adults, particularly those with hearing loss, may take into consideration co-
existing psychosocial conditions such as depression when considering dementia 
prevention and intervention strategies. Identification of low-risk intervention 
options for dementia among subgroups of older adults at a particularly greater 
risk for cognitive decline or dementia could vastly improve public health 
strategies as well as quality of life for older adults. 
   
5.2 Challenges 
In analyses presented here, we acknowledge the limitations with 
audiologic measures completed 4 years after baseline in the Health ABC Study. 




using Year 1 as baseline for our analysis. While this presents a chronological gap 
from when hearing was measured, for the majority of older adults, hearing 
changes very gradually, at a rate of 1-2 dB per year1 and is an approach which 
has been used in other studies2-3. Thus, the time between baseline and when 
audiometry was performed likely only presents a minimal change in hearing for 
most participants. We therefore do not expect significant misclassification by 
hearing category – any misclassification would likely lead to a conservative 
estimate of the association observed between hearing and depressive symptoms 
across our analyses performed.  
We were additionally not able to assess medication use for depression 
beyond year 6 in the Health ABC study. Albeit the CES-D 10 demonstrates good 
sensitivity in identifying those with significant depressive symptoms, it is not a 
diagnostic measure for depression. This assessment may incorrectly capture 
constructs of depression that are more appropriate for older adults and result in 
misclassification of depressive symptoms. It is also possible that participants 
were biased in their reporting of their depressive symptoms, potentially due to 
perceived stigma associated with depression. Additionally, our investigation of 
risk factor exposure and rates of cognitive change or incident dementia was 
limited to one/two tests of cognitive function. A more comprehensive test battery 
including neurocognitive assessment across multiple domains, especially 
memory and executive function, and using both auditory and visual modalities 
will further enlighten our understanding of how hearing loss in conjunction with 




While we performed sensitivity analysis adjusting for hearing aid use, our 
measure of hearing aid use is crude and self-reported, leaving potential room for 
misclassification as many adults over-report their hearing aid use4. Continued 
investigation of how the management of hearing loss may influence downstream 
psychosocial outcomes using a more specific and valid assessment of hearing 
aid use may greatly improve our understanding of how intervention on these 
measures may reduce dementia risk and have far-reaching public health impact. 
Current clinical trials of hearing aid use among older adults are underway and 
may further aid in our understanding and quantification of the broad benefits of 
hearing management. 
Presenting opportunity for further research, our analyses were not able to 
investigate associations by central hearing ability, as measures of central hearing 
were not available from the Health ABC study. Further research on this 
association may shed light on how an individual’s functional hearing ability may 
present differing associations than measures of peripheral hearing loss.  
Consideration of how central hearing ability, which has been suggested as an 
early marker of incident dementia, might influence vulnerability to late-life 




Our review of the hearing-dementia association provided not only a 




it additionally incorporated proposed targeted areas for future research which 
may present the largest potential public health impact.  The analyses presented 
capitalize on the use of a well-defined and carefully designed longitudinal cohort 
of community-dwelling older adults. Within this cohort, we were able to complete 
longitudinal investigations on the association between hearing loss and 
depressive symptoms. By evaluating depressive symptoms over time, we 
quantified both how hearing loss contributed to the presence of depressive 
symptoms and recurrent or prolonged depressive symptomatology, which is 
associated with significant negative health outcomes in older adults5-6. We were 
additionally able to investigate how the variable presentation of depressive 
symptoms may add to the risk associated with hearing loss or influences risk of 
cognitive change or incident dementia.  
  
5.4 Implications and future directions 
The thesis work presented here expands on our current understanding of 
the influence of hearing loss on late-life mental health and depression but leaves 
many avenues of research open for investigation and highlights key directions for 
future study. In Chapter 2 we provided a detailed discussion of selected future 
directions for research which in our view might best inform our investigation of 
the potential casual association between hearing and dementia. First, we 
discussed elucidation of the driving mechanism behind the hearing-cognition 
association. If we can determine the link(s) or driver(s) behind the association of 




intervention options to delay the onset or alter the trajectory of the clinical course 
of dementia.  How best to intervene, and ultimately whether treatment for hearing 
loss will be effective in decreasing or delaying dementia risk, largely depends on 
the underlying mechanism. In all likelihood, multiple mechanisms are involved in 
the hearing-dementia association; thus, further investigation should determine if 
one mechanism serves as a primary driver and how each may interact to alter 
risk. It is possible the primary driver is unique to the individual, allowing for a 
person-centered approach to intervention that alters the progression to dementia.  
Next, we expressed a need to understand how treating hearing loss 
influences dementia risk- either directly or by also reducing the risk for other risk 
factors for dementia. Evidence for the impact treating hearing impairment has on 
cognitive decline or dementia is accumulating. However, until the results of the 
current longer-term clinical trials are available, the evidence of these effects on 
cognitive decline and dementia risk largely stem from observational studies 
which, while powerful in their right, present challenges for causal inference. We 
review how a framework of public health prevention strategies recognize the 
potential for targeted intervention at each stage of the disease process— known 
as primary, secondary, and tertiary prevention7, and provide examples of 
intervention strategies at each stage of prevention. Evidence for hearing 
intervention at these levels of prevention remains limited, and an understanding 
of how hearing loss treatment throughout the process might influence upstream 




Lastly, in Chapter 2 we discussed a need to determine the most 
appropriate way to measure hearing ability among adults when estimating 
dementia risk. Consideration of self-reported hearing, peripheral hearing ability, 
central hearing ability, and electrophysiologic measures may all have a role in 
identifying those who may present an increased risk for dementia. Yet current 
research remains limited in our ability to understand how measures of different 
aspects of the hearing system may inform risk. Additionally, we must also ensure 
we maintain fidelity of cognitive tests among those with hearing impairment, or 
any sensory impairment, as well as of sensory evaluation among those with more 
advanced cognitive impairment.  
The analyses presented in this thesis presented additional future 
directions for research. There is need for detailed investigation of social 
influences by race and gender or other identifying factors on the association 
between hearing loss and late-life mental health. While evidence for associations 
between hearing loss and late-life mental health has been growing, what has 
received minimal attention is how social constructs, stressors, and demands 
related to personal characteristics like race and gender may influence the 
associations observed. Known differences in the prevalence of late-life mental 
health conditions, including late-life depression and dementia, by race and/or 
gender exist8-9. Late-life depression is more prevalent in women compared to 
men, yet these differences are shown to decrease after age 8510-11. Women 
traditionally rely on communication to maintain intimacy and connectedness and 




this connection which has been linked to decreased depressive symptoms may 
foster identification of avenues for prevention or intervention for novel means of 
supporting connection. Understanding how social factors across cohorts of older 
adults may influence this social support and social networks may further highlight 
ways in which we may support older women or men with hearing loss, both in 
prevention of depression, but also as a means of intervention for dementia or 
other mental health outcomes. 
Further, minority adults have been shown to generally present with higher 
levels of depressive symptomatology but lower levels of major depressive 
disorder compared to non-Hispanic white adults in the U.S.10,13. Decades of 
social stressors, disparities, and reduced uptake of health services are 
hypothesized to increase vulnerability of minority adults in the U.S. to depressive 
symptomatology8. How the additional presence of hearing loss may add to these 
stressors or prolong poorer depressive symptom trajectory requires more 
detailed study. Additionally, how the mental-health stressors experienced by 
minority older adults with hearing impairment in the U.S. may further increase 
dementia risk requires more investigation but may again spotlight potential 
avenues for prevention or intervention.  
  
5.5 Implications for clinical practice 
How auditory scientists, cognitive scientists, epidemiologists, and other 
investigators present the research on hearing and cognitive impairment can have 




families, as was discussed extensively in Chapter 2. We posited how, given the 
varied disciplines involved in research on hearing and cognitive impairment, 
understanding how to synthesize the current evidence, translate findings, and 
guide future research for scientific progression is vital. However, current research 
has primarily remained siloed within disciplines. Auditory science and cognitive 
science researchers have the opportunity and expertise to address aspects of 
the primary research gaps described above. Transparency of and careful 
consideration of study design, measurement tools implemented, and discussion 
of results’ applicability for clinical or community populations is essential to 
characterize the role of hearing impairment within the dementia timeline and 
meet the needs of our current and future older adults. 
The growing prevalence of older adults means parallel growth in the 
number of hearing impaired older adults.  This growth necessitates early 
intervention and exploration of preventive measures amenable to the unique and 
often complex needs of this population. The interdependence of hearing loss and 
neuropsychiatric disorders may provide opportunity for interdisciplinary 
intervention and concomitant benefit on outcomes beyond the proposed target of 
depression or dementia. Prior work has demonstrated feasibility and potential 
benefit of the use of hearing aids as a therapeutic agent for depression. 
Exploration of paths between individual behaviors and successful hearing aid use 
may improve therapeutic effectiveness by providing a non-pharmacological, low 
risk and under-utilized approach for late-life depression or dementia and may 




burden of these conditions through aural rehabilitation and combined intervention 
strategies could have far-reaching incidental benefit. Appropriately identifying 
patient candidates who could most benefit from targeted social or aural 
rehabilitation intervention improves the effectiveness of valuable patient-provider 
interactions and maximizes the potential for success. Investigation on how 
accounting for hearing loss may improve patient’s understanding of medical 
recommendations, treatment compliance, or effectiveness when paired with non-
pharmacological treatments is in its infancy. However, this mindfulness towards 
care may shed light on how considerations of hearing loss and its negative down-
stream consequences may have broad implications for health services and 
related outcomes. 
With additional insight gained, we may further be able to determine during 
patient interactions when may be most advantageous to intervene on hearing 
loss. It is possible initiation of hearing aid use for neuropsychiatric conditions may 
be less effective than simple employment of communication strategies to address 
hearing loss, or that initiation should be delayed/initiated during specific times 
within the mental-health management process. It is also possible initiation of 
hearing aid use once certain symptomatology has manifested is ineffective due 
to already altered brain pathology. This suggests early adoption of hearing aids 
upon identification of hearing loss prior to the onset of late-life mental health 
concerns may be a more effective management strategy and may support 




Our results additionally highlight the inter-relational connection between 
medical conditions for older adults. These findings underscore how a multi-
domain approach for intervention and prevention of late-life mental health 
concerns may provide a more comprehensive person-centered approach to care. 
Our results support prior work demonstrating an association between hearing 
loss and depressive symptoms as well as dementia. Moreover, our results 
suggest greater risk of poorer cognitive outcomes among those with both hearing 
loss and significant depressive symptoms – greater than that expected by the 
presence of both conditions in isolation. While attentiveness to multimorbidity in 
dementia prevention has been considered in past trails such as the Finnish 
Geriatric Intervention Study to Prevent Cognitive Impairment and Disability 
(FINGER) Study14, inclusion of hearing within this approach to intervention 
design has been limited. However, consideration of hearing loss within a 
multimodal intervention for in-patient delirium has shown promise15. Hearing loss 
has been associated in epidemiologic work with many negative health outcomes 
for older adults16-18, many of which may also increase risk for dementia or other 
late-life mental health conditions19. Thus, primary care or geriatric providers may 
consider hearing loss or the management of hearing loss within the context of 
multimorbidity, potentially as a means of both intervention and prevention for 






Our working knowledge of the association between hearing loss and 
cognition has drastically expanded over recent decades. However, gaps in 
understanding and avenues for targeted research remain and leave significant 
room for public health intervention given the high prevalence of hearing loss 
among older adults. We found evidence supporting an association between 
hearing loss and negative late-life mental health outcomes. Specifically, we 
conclude hearing loss may increase risk of depressive symptoms in older adults. 
Furthermore, the presence of both hearing loss and depressive symptoms, each 
independent risk factors for dementia, resulted in steeper rates of cognitive 
decline and highest estimated risk for dementia. Consideration of hearing loss 
and its management strategies within health care and research settings may 
open doors for innovative intervention strategies and reduced late-life mental 
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Appendix A.1 Model fit statistics for determination of class number for 
Depressive Symptom Trajectory 
 
1 class 2 class 3 class 4 class 
AIC 42285.21 41934.55 41576.24 41492.46 
BIC 42336.01 42002.28 41672.19 41610.99 
LMR LRT p N/A 0.000 N/A N/A 
Boot LRT p N/A 0.000 0.00 0.00 
Entropy N/A 0.852 0.742 0.7 
Latent Class 1 
(%) 
2089 (100%) 1877 
(89.85%) 
566 (27.1%) 377 (18.0%) 




1390 (66.6%) 86 (4.1%) 
Latent Class 3 
  
132 (6.3%) 601 (28.8%) 
Latent class 4 






Danielle S. Powell 
2024 E. Monument St. Suite 2-700. Baltimore MD, 21205 
dpowel33@jhu.edu | 713-553-4726 
 
Education 
Johns Hopkins University                   
Baltimore, MD 
PhD candidate, Bloomberg School of Public Health, Epidemiology       August 2017-Present 
Certificate of Gerontology         January 2018-Present 
University of North Carolina                                   
Chapel Hill, NC 
Doctor of Audiology                                              May 2013 
Northwestern University                                           
Evanston, IL 
B.S. in Communication Sciences and Disorders                                         May 2009    
 
Fellowships and Grants 
• Cochlear Center on Hearing Loss and Public Health Fellow (2018-present) 
o Access to a multi-disciplinary team of experts who specialize in studying the 
impact of hearing loss on older adults and public health. Receives training on 
designing and implementing research studies as well as intervention strategies to 
improve health; attends seminars, hosts journal clubs and presents at research 
conferences 
• T32 Epidemiology and Biostatistics of Aging Training Program (2017-2019) 
o Interdisciplinary training and collaboration regarding the conduct and 
methodology of public health research in older adults 
• Pediatric Audiology Training Grant (2009-2011) 
o Completed over 400 hours of pediatric clinical training at various clinical sites. 
o Presented a poster at the UNC Student Research Forum on the feasibility of 
using various school hearing screening methods in Guatemala. 
• Leadership Education in Neurodevelopmental Disabilities (LEND) Training Grant (2009-
2011) 
o Completed a year-long course with 4 other health related disciplines that focuses 
on how to effectively collaborate with interdisciplinary groups in order to serve 
individuals with disabilities. 
 
Certifications 
ASHA Certificate of Clinical Competence in Audiology             
Obtained May 2013 
Licensed Audiologist for the District of Columbia              
Obtained May 2014 
 
Professional Experience 
Clinical Audiologist       June 2014 to July 2017 
George Washington University Medical Faculty Associates, Washington, DC 




Otolaryngology Associates, Fairfax, VA        
            
 
Research Experience 
• Dissertation: Hearing Loss and Late-Life Mental Health in Older Adults 
o Aim 1: Hearing and Dementia- current evidence and future perspectives 
o Aim 2: Hearing loss and depressive symptoms in older adults in the Health 
ABC 
o Aim 3: The joint effects of hearing loss and depressive symptoms on 
cognitive change and incident dementia 
• Research Assistant for the Cochlear Center for Hearing and Public Health  
o The association between hearing loss and diabetes 
o Speech-in-noise performance and depressive symptoms in older adults 
o Self-Report Hearing and Falls in NHIS 
o Systematic Review of Sensory Bias in Neurocognitive Research 
o Invited piece - “Hearing and Dementia: Review and future work” 
• Graduate LEND Researcher at UNC- Chapel Hill  
 
Invited Talks, Interviews, Presentations and Posters 
• Invited Panelist. Audiology with an Emphasis on public health applications. 
American Speech-Language Hearing Association Special Interest Group: 
Audiology and Public Health; February 25, 2021. 
• Powell DS, Betz J, Yaffe K, Kritchevsky S, Strotmeyer E, Simonsick E, Lin F, 
Gross A, Deal J. Hearing Impairment and Risk of Depression in Older Adults in 
Health ABC. Gerontological Society of America Conference; November 2020 
(oral presentation) 
• Powell DS, Kuo P, Deal JA, Gross AL. The Relationship of APOE ɛ4 to the 
Relative Times and Hazards of Dementia. Cognitive Aging Conference, Atlanta, 
GA, April 16, 2020. (poster presentation accepted-conference postponed) 
• Reed NS, Garcia EE, Powell DS, Lin FR, Palta P, Deal JA. Impaired Speech in 
Noise and Depressive Symptoms in Older Adults. 2020 Scientific Technology 
Meeting of the American Auditory Society, Scottsdale, AZ, March 5-7, 2020. 
(poster presentation, Powell DS presented) 
• Powell DS, Kuo P, Deal JA, Gross AL. The Relationship of APOE ɛ4 to the 
Relative Times and Hazards of Dementia. Gerontological Society of America 
Conference; November 13-17, 2019. Austin Tx. (oral presentation) 
• Powell DS, Deal J, Sharrett A, Lin F, Gross A. Hearing Loss and Mental Health 
Outcomes in Older Adults: A Proposal. Cochlear Center Research Day. 
Baltimore, Maryland. March 25, 2019. (poster presentation) 
• Powell DS, Deal J, Gross A. Hearing Loss and Mental Health Outcomes in Older 
Adults. Epidemiology and Biostatistics of Aging Research in Progress. 
Baltimore, Maryland. February 11, 2019. (oral presentation) 
• Powell DS, Neiman C. Innovations in Hearing Care. Broadmead Retirement 
Center. Baltimore, Maryland. October 15, 2018 (community oral presentation) 
• Powell DS, Mamo S, Sundberg J, Roush J. Cultural Competency: Lessons from 
Community-Based Learning in Guatemala. North Carolina American Academy 
of Audiology, 2010 (poster presentation) 
 
Publications 
• Powell DS, Deal JA, Goman AM. Reconsidering Those with Normal Hearing. JAMA 




• Powell DS, Garcia Morales E, Pletnikova S, Deal J, Reed N. Self-Report Hearing 
and Injury or Falls in Older Adults from the National Health and Information 
Survey. [Seminars in Hearing, In press] 
• Powell DS, Kuo P, Qureshi R, Coburn S, Knopman D, Palta P, Gottesman R, 
Griswold M, Albert M, Deal J, Gross A. The Relationship of APOE ɛ4, Race, and 
Sex on the Age of Onset and Risk of Dementia.[Under Review at Neurology] 
• Powell DS, Oh E, Lin FR, Deal JA. Hearing and Cognition in an Aging World. 
[Journal of the Association of Research on Otolaryngology, In press] 
• Powell DS, Oh E, Reed N, Lin FR, Deal JA. Hearing and Cognition in an Aging 
World. [Invited and accepted abstract for special issue of Frontiers in Aging-
Neuroscience]. 
 
Technical Reports and other Manuscripts 
• Powell DS, Deal JA. Hearing and Dementia- A Look Ahead. Minnesota Academy 
of Audiology Annual Newsletter; January 2021. 
• Contributing author of background paper. World Report on Hearing. Geneva: 




Honors and Awards 
• Department of Epidemiology Travel Award 
Memberships 
• Society of Epidemiologic Research 
• SENSE Matters Network Member 
• Gerontological Society of America 
o ESPO Annual Scientific Meeting Working Group appointee (January 1, 2021-
December 31, 2021) 
o Epidemiology Interest Group 
o Sensory Loss Interest Group 
• Member of the Coalition for Global Hearing Health 
• Member of the International Society of Audiology 
• American Speech-Language Hearing Association, CCC-A 
o ASHA 2021 Hearing, Tinnitus, and Vestibular Science Program Committee 
o Special Interest Group- Audiology and Public Health Programming Committee 
 
Trainings and Certificates 
• Johns Hopkins University Teaching Institute Certificate (May 2018) 
o Completed Teaching Assistanceship Training: Essential TA elements course, 
Johns Hopkins Center for Teaching and Learning, Baltimore MD 
• Johns Hopkins University Certificate of Gerontology (January 2018- present) 
• Global Health Certificate- UNC Gillings School of Public Health (2013) 
 
Manuscript Reviews  
• Psychology and Aging 
• International Journal of Audiology 
• JAMA Otolaryngology 
• Ear and Hearing 




• Nature-Scientific Reports 
• Speech Language Hearing 
 
Current Statistical Software Experience: STATA and MPlus 
 
Teaching Experience and Additional Skills  
• Teaching Assistant 
o Epidemiology of Sensory Loss in Aging (Winter 2020) 
o Epidemiology of Aging (Fall 2019) 
o Principles of Epidemiology (2018) 
o Epidemiologic Methods II (2018) 
o Introduction to Hearing Aids Course (Spring 2012) 
 
• Classroom Instruction 
o Epidemiology of Sensory Loss in Aging (Winter 2020) 
 1 lecture and Measurement Lab on hearing measures  
o Introduction to Hearing Aids Course (Spring 2012) 
 8 hands-on labs for hearing aid management, verification and 
programming  
 
• Graduate Research Assistant: Cochlear Center for Hearing and Public Health (summer 
2018-present) 
• Johns Hopkins Epidemiology Doctoral Student Representative 
• Johns Hopkins Epidemiology Centennial Celebration Student leader 
• Johns Hopkins Bloomberg School of Public Health Research on Aging Showcase Co-
President 
• Johns Hopkins Cochlear Center for Hearing and Public Health Journal Club Coordinator 
• Ruth Uppercru Paul Fund 
o Member of Committee through the GW Medical Faculty Associates in 
establishing a need-based fund and program to provide hearing aids and 
services to Greater Washington DC area residents; creating a sustainable and 
community oriented program and research. 
• Coalition for Global Hearing Health- Advocacy Committee (October 2015-2017) 
